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Abstract: The synthesis of a small library of dihydrouracils spiro-fused to pyrrolidines is 
described. These compounds are synthesized from β-aryl pyrrolidines, providing products 
with the 2-arylethyl amine moiety, a structural feature often encountered in compounds 
active in the central nervous system. The β-aryl pyrrolidines are synthesized through a 
three-step methodology that includes a Knoevenagel condensation reaction, a 1,3-dipolar 
cycloaddition reaction, and a nitrile reduction. 
Keywords: Knoevenagel condensation; 1,3-dipolar cycloaddition; azomethine ylide; 
parallel synthesis; spiro dihydrouracils 
 
1. Introduction 
The 2-arylethyl amine moiety 1 (Figure 1) is an important privileged structure, which is 
encountered in numerous compounds active in the central nervous system (CNS). This privileged 
structure is present in neurotransmitters such as dopamine, epinephrine, norepinephrine, and serotonin 
[1]. Salmeterol [2,3] and venlafaxine [4–6], two of the ten best-selling prescription drugs in 2006 [7], 
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also contain this moiety. In addition, the 2-arylethyl amine unit occurs in many hallucinogenic drugs, 
such as LSD, MDMA (ecstasy), mescaline, and psilocybin (magic mushrooms) [8,9]. 
Figure 1. 2-Arylethyl amine (1), uracil (2), thymine (3), and zidovudine (AZT, 4). 
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On the other hand, pyrimidine-2,4-diones are a class of bioactive heterocyclic molecules, the most 
famous examples being uracil (2) and thymine (3, Figure 1), which form part of the nucleotides of 
RNA and DNA, respectively [10]. Pyrimidine-2,4-diones have attracted considerable attention in the 
pharmaceutical industry as anti-inflammatory agents [11], dopamine receptor agonists [12], serotonin 
uptake inhibitors [13], and antiepileptic agents [14]. A good example of a pyrimidine-2,4-dione 
derivative with a medicinal application is zidovudine (AZT, 4, Figure 1), used as an anti-AIDS agent 
[15]. This moiety is also the core structural element of some fungicides [16] and herbicides [17]. 
It is known that the difference in activity and receptor selectivity of drugs might be explained by the 
conformation of the contained privileged structure. Generation of semi-rigid drugs facilitates the study 
of their interactions with the receptors, may lead to more selective interactions with fewer side effects, 
and permits the rational design of more potent and selective drugs in the future [18,19]. Herein we 
present the parallel synthesis of a library comprised of compounds combining all the above features 
(Scheme 1). First, these compounds possess a β-aryl pyrrolidine with a conformationally constrained 
2-arylethyl amine. Second, they are semirigid structures because of the spiro fusion to a dihydrouracil. 
It is known that the combination of privileged structures can lead to new chemical entities that may 
have pharmacological relevance [20,21] and increase the structural diversity. 
Scheme 1. Combination of two privileged structures to generate a product with increased rigidity. 
1   +   2 HN
NH
NO O
R
Ar
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2. Results and Discussion 
We envisioned that a suitable strategy to synthesize these compounds may proceed as shown 
retrosynthetically in Scheme 2. The spiro dihydrouracils 5 could be synthesized by an annulation 
reaction of α-aminomethyl esters 6 and an isocyanate. The aminomethyl group of compounds 6 could 
be derived from a masked amino function, such as a cyano group, by reduction. Compounds 7 possess 
two electron-withdrawing groups at the carbon in the 3-position of the pyrrolidine, rendering it a 
perfect pattern for preparation by a 1,3-cycloaddition reaction of an azomethine ylide and an electron-
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deficient alkene. This would leave the 3-aryl-2-cyanoacrylates 8 as starting materials, which could be 
obtained by the Knoevenagel condensation reaction of methyl 2-cyanoacetate (9) and an aromatic 
aldehyde. 
Scheme 2. Retrosynthetic analysis for the synthesis of spiro dihydrouracils 5. 
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2.1. Knoevenagel condensation reaction 
The synthesis of compound class 5 commenced with the condensation reaction of methyl 2-
cyanoacetate (9) and aromatic aldehydes 10. Twelve aldehydes 10{1–12} (electron-rich aromatic, 
electron-rich heteroaromatic, and electron-poor heteroaromatic aldehydes; Figure 2) were selected for 
the formation of the scaffolds. 
Figure 2. Aromatic aldehydes 10{1–12} used for the Knoevenagel reaction. 
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The reaction conditions for the Knoevenagel condensation reaction are critically dependent on the 
electron-withdrawing groups bound to the activated methylene [22] and need to be optimized in every 
case. Initially, these reactions were performed using EtOH as solvent, but transesterification (up to 
3%) was observed and the resulting mixture of methyl and ethyl esters was impossible to separate. 
These reactions also took place in THF (see entry 8, Table 1), but required a longer reaction time. 
Finally, treatment of 9 with a catalytic amount of piperidine in MeOH (except for entry 8 because of 
the low solubility of 10{8} in MeOH) at room temperature produced the desired acrylates 8{1–12} in 
excellent yields (Table 1). All these compounds are only sparingly soluble in MeOH, allowing the pure 
crystalline products to be easily collected by filtration. These products can also be recrystallized from 
MeOH yielding crystals of >99.5% purity. The reaction was completely stereoselective in all cases 
[23], only the E alkenes were observed as could be inferred from the 13C-NMR coupling constants 
between the olefinic proton and the carbon atoms of the ester and the nitrile [24,25]. These values are 
3J = 6.6–6.9 Hz for the carbonyl group and 3J = 13.6–13.9 Hz for the cyano group. The Knoevenagel 
adducts are stable at room temperature and unreactive towards the regular atmosphere, therefore 
remain unchanged for months. 
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Table 1. Knoevenagel condensation reaction to form the 2-cyanoacrylates 8{1–12}. 
10{1–12}, piperidine
MeOH, 21 °C
8{1–12}
NC CO2Me
NC CO2Me
Ar
9
ArCHO
 
Entry ArCHO Product Time (min) 
Yield 
(%) 
1 10{1} 8{1} 30 99 
2 10{2} 8{2} 30 94 
3 10{3} 8{3} 40 99 
4 10{4} 8{4} 60 99 
5 10{5} 8{5} 120 95 
6 10{6} 8{6} 120 96 
7 10{7} 8{7} 30 99 
8 10{8} 8{8} 480a 99 
9 10{9} 8{9} 30 94 
10 10{10} 8{10} 30 99 
11 10{11} 8{11} 90 93 
12 10{12} 8{12} 25 99 
a THF was used as solvent. 
2.2. 1,3-Dipolar cycloaddition reaction 
The next step in the synthesis was the formation of the pyrrolidine-core structures by a 1,3-dipolar 
cycloaddition reaction using an azomethine ylide. This reaction is an important method for the 
formation of pyrrolidines [26] and has been used in the synthesis of natural products [27,28]. Among 
the vast number of procedures for making azomethine ylides [29–41], the decarboxylative 
condensation of α-amino acids with aldehydes, typically heated in toluene or DMF, was chosen [42]. 
Thus, the reaction of paraformaldehyde and sarcosine (N-methylglycine) in refluxing toluene in the 
presence of the 2-cyanoacrylates 8 cleanly provided the desired pyrrolidines 7, containing the 2-
arylethyl amine motif (Table 2). The reaction was clean to such an extent that in some cases an 
extraction (H2O/Et2O) was all the purification needed (or just a short column chromatography). The 
reaction was totally stereospecific in most cases (entries 1–6 and 8), highly stereospecific for 8{9} 
(entry 9), and partially stereospecific for the electron-poor heteroaryls 8{10–12} (entries 10–12) [43]. 
The mixtures of diastereoisomers that arose could not be separated by column chromatography. The 
reaction did not take place with compound 8{7} (entry 7); after 4 h only some minor unidentified 
compounds were formed and most of the substrate was recovered, but there was no trace of compound 
7{7}. The reaction of substrate 8{5} did form the product 7{5}, but with a lower yield compared to all 
the others. The reaction of substrate 8{8} formed the expected cycloadduct, but the indolic nitrogen 
was (dimethylamino)methylated during the reaction. 
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Table 2. 1,3-Dipolar cycloaddition reaction to form the pyrrolidine-core structures 7. 
MeNHCH2CO2H
(CH2O)n, PhMe, Δ
MeN
CO2Me
CN
Ar
7{1–6,9–13}8{1–12}
NC CO2Me
Ar
 
Entry Acrylate Product(s)a Time (min) 
Yield 
(%) 
1 8{1} 7{1} 20 94 
2 8{2} 7{2} 75 99 
3 8{3} 7{3} 80 95 
4 8{4} 7{4} 80 99 
5 8{5} 7{5} 120 52 
6 8{6} 7{6} 80 95 
7 8{7} 7{7} 240 – 
8 8{8} 
MeN
CO2Me
CN
N
NMe2  
7{13} 
150 85 
9 8{9} 7{9} +
MeN
CO2Me
CN
S  
11{9} 
80 87b 
10 8{10} 7{10} +
MeN
CO2Me
CN
N
 
11{10} 
45 90c 
11 8{11} 7{11} +
MeN
CO2Me
CN
N  
11{11} 
25 72d 
12 8{12} 7{12} +
MeN
CO2Me
CN
N  
11{12} 
45 85e 
a Ratio calculated by integration of the 1H-NMR signals of the crude reaction mixture;  
b 7{9}/11{9} = 70:1; c 7{10}/11{10} = 6.5:1; d 7{11}/11{11} = 6.6:1; e 7{12}/11{12} = 5:1 
After analysis of the results obtained so far, it was decided to continue the research only with the 
diastereomerically pure compounds 7{1–6} for the construction of the library scaffolds. 
2.3. Reduction 
The chemoselective reduction of the nitrile was best achieved by a heterogeneous catalytic 
hydrogenation using Raney nickel under a hydrogen atmosphere at room temperature (Table 3) [44]. 
We found that the addition of NH3 or Et3N was crucial for the reaction to go to completion [45]. 
Eventually, Et3N was used since with NH3 amide 12 (Figure 3) was formed alongside the product. 
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Figure 3. Amide 12 formed. 
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Thus, compounds 7{1–6} were reacted under these conditions to complete the synthesis of the 
library scaffolds. After elimination of Raney nickel by filtration through diatomaceous earth and 
evaporation of MeOH and Et3N, the reaction cleanly gave the α-aminomethyl esters 6{1–6}. 
Table 3. Reduction of the cyano group from the α-cyano esters 7. 
MeN
CO2Me
NH2MeN
CO2Me
CN
Ar
H2, Ra-Ni, Et3N
MeOH, 21 °C, 15 h
Ar
7{1–6} 6{1–6}  
Entry Substrate Product Yield (%) 
1 7{1} 6{1} 95 
2 7{2} 6{2} 95 
3 7{3} 6{3} 89 
4 7{4} 6{4} 85 
5 7{5} 6{5} 73 
6 7{6} 6{6} 95 
2.4. Parallel synthesis of spiro dihydrouracils 
The procedure followed for the formation of the spiro dihydrouracils was formation of a urea by 
addition of an isocyanate and subsequent cyclization by reaction with a base. The conversion of 
chemset 6 into chemset 5 was accomplished using reagent chemset 13. Eight isocyanates 13{1–8} 
(alkyl, electron-rich aryl, electron-poor aryl, and heteroaryl isocyanates; Figure 4) were selected for 
the generation of a 48-compound library. 
Figure 4. Isocyanates 13{1–8} used for the reaction of scaffolds 6{1–6}. 
NCO NCO
Ph
NCO
EtO2C
NCO
NCO NCO NCO NCO
NF3C EtO
NC
1 2 3 4
8765  
The reactions for the formation of the α-ureidomethyl esters were run in either CH2Cl2 or DMF 
depending on reagent solubility and reactivity. Thus, the reactions of 6{1–6} and 13{1,3–5} in CH2Cl2 
for 15 h at room temperature afforded the corresponding α-ureidomethyl esters. In order to reach full 
conversion to the α-ureidomethyl esters using isocyanates 13{2,6–8}, DMF at 80 °C for 15 h had to be 
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used. After evaporation of the solvent, the crude mixture was dissolved in THF and 1 M KOBut in 
THF (1 equiv) was added [46,47]. The reactions were stirred at room temperature for 15 h and the 
solvent was evaporated. Liquid–liquid extraction afforded two different types of compounds, 
depending on the isocyanate used: (1) the alkyl isocyanates 13{1–3} gave the expected 4-aryl-
spiro[dihydrouracil-5,3′-pyrrolidines] 5{1–6,1–3} with yields ranging from 49 to 80% (61% average) 
and with purities ranging from 60 to 99% (83% average; Scheme 3 and Table 4) according to LC-MS 
analysis (also confirmed by 1H-NMR spectroscopy) and (2) the aryl isocyanates 13{4–8} gave mostly 
the unexpected α-ureidomethyl acids 14{1–6,4–8} with yields ranging from 45 to 79% (64% average) 
and with purities ranging from 0 to >99% (82% average; Scheme 4 and Table 5) according to LC-MS 
analysis (also confirmed by 1H-NMR spectroscopy). 
Scheme 3. Spiro dihydrouracil formation from scaffolds 6{1–6}. 
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Scheme 4. α-Ureidomethyl acid formation from scaffolds 6{1–6}. 
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The reactions carried out with reagent 13{1} resulted in high purities (89% average) for the 
formation of the spiro dihydrouracils, due to lack of competing reactions. The purities of the products 
from the reactions run in DMF (reagent 13{2}) were in the range 60 to 92% (70% average). These 
lower purities could be due to partial decomposition of the isocyanates at the temperature used for the 
reactions in DMF. The reactions carried out with reagent 13{3} gave a mixture of the expected ethyl 
esters 5{1–6,3}, the methyl esters 5{1–6,9} (from transesterification of the ethyl ester on the R group 
by methoxide, formed in the cyclization), the acids 5{1–6,10} (from hydrolysis of the esters), and the 
deorganylated compounds 5{1–6,11} (Figure 5 and Table 4). The overall cyclization reaction worked 
well, since products 5{1–6,9}, 5{1–6,10}, and 5{1–6,11} were formed from 5{1–6,3}. Shorter 
reaction times should thus be used to avoid these side reactions. 
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Figure 5. Products formed from the reaction with reagent 13{3}. 
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The above-mentioned deorganylation side reaction could have taken place through an E1cB 
mechanism (Scheme 5). The substrate 5{1–6,3} (or 5{1–6,9}) is deprotonated to form the enolate 
5{1–6,12}, which undergoes an elimination reaction to afford 5{1–6,11} after work-up. 
Scheme 5. Formation of compounds 5{1–6,11}. 
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The aryl-substituted dihydrouracils underwent hydrolysis (and not the alkyl-substituted 
dihydrouracils) because the electrophilicity of the ureide carbonyls is enhanced (with respect to the 
alkyl group) due to the conjugation of the imide-type nitrogen with the aryl group. Thus, residual H2O 
from KOBut could have hydrolyzed the ureide to the ureido acid [48]. 
Table 4. Parallel synthesis of spiro dihydrouracil library 5{1–6,1–3}a,b. 
MeN
NH
NO O
MeN
NH
NO O
Ph
MeN
NH
NO O
R
 
5{1,1} 
51% (89%) 
5{1,2} 
63% (70%) 
5{1,3} 
80% (91%)c 
MeN
NH
NO O
OMe  
MeN
NH
NO O
Ph
OMe
MeN
NH
NO O
R
OMe  
5{2,1} 
60% (93%) 
5{2,2} 
64% (60%) 
5{2,3} 
49% (88%)c 
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Table 4. Cont. 
MeN
OMe
OMe
NH
NO O
 
MeN
OMe
OMe
NH
NO O
Ph
MeN
OMe
OMe
NH
NO O
R
 
5{3,1} 
66% (90%) 
5{3,2} 
60% (68%) 
5{3,3} 
54% (95%)c 
MeN
NH
NO O
O
O
MeN
NH
NO O
Ph
O
O
MeN
NH
NO O
R
O
O
 
5{4,1} 
63% (95%) 
5{4,2} 
64% (68%) 
5{4,3} 
61% (98%)c 
MeN
N
Me
NH
NO O
MeN
N
Me
NH
NO O
Ph
MeN
N
Me
NH
NO O
R
 
5{5,1} 
61% (99%) 
5{5,2} 
54% (92%) 
5{5,3} 
66% (79%)c 
MeN
NH
NO O
N
Me
MeN
NH
NO O
N
Me
Ph
MeN
NH
NO O
R
N
Me  
5{6,1} 
69% (69%) 
5{6,2} 
68% (62%) 
5{6,3} 
62% (86%)c 
a % = Crude yield based on mass recovery; b (%) = Purity determined by LC-MS at 215 nm;  
c Mixture of compounds, R = CH2CH2CO2Et, CH2CH2CO2Me, CH2CH2CO2H, and H. 
Table 5. Parallel synthesis of α-ureidomethyl acid library 14{1–6,4–8}a,b. 
MeN
N
H
N
H
OCO2H
 
MeN
N
H
N
H
OCO2H
CF3
 
MeN
N
H
N
H
OCO2H
OEt
MeN
N
H
N
H
OCO2H
CN
 
MeN
N
H
N
H
OCO2H
N
14{1,4} 
49% (>99%) 
14{1,5} 
75% (97%) 
14{1,6} 
48% (>99%) 
14{1,7} 
54% (>99%) 
14{1,8} 
49% (79%) 
MeN
N
H
N
H
OCO2H
OMe  
MeN
N
H
N
H
OCO2H
OMe
CF3
 
MeN
N
H
N
H
OCO2H
OMe
OEt
MeN
N
H
N
H
OCO2H
OMe
CN
 
MeN
N
H
N
H
OCO2H
N
OMe
14{2,4} 
60% (99%) 
14{2,5} 
65% (98%) 
14{2,6} 
70% (>99%) 
14{2,7} 
60% (96%) 
14{2,8} 
45% (76%) 
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Table 5. Cont. 
MeN
N
H
N
H
OCO2H
OMe
OMe  
MeN
N
H
N
H
OCO2H
OMe
OMe
CF3
 
MeN
N
H
N
H
OCO2H
OMe
OMe
OEt
MeN
N
H
N
H
OCO2H
OMe
OMe
CN
 
MeN
N
H
N
H
OCO2H
N
OMe
OMe
14{3,4} 
76% (97%) 
14{3,5} 
63% (99%) 
14{3,6} 
52% (99%) 
14{3,7} 
58% (>99%) 
14{3,8} 
48% (43%) 
MeN
N
H
N
H
OCO2H
O
O
 
MeN
N
H
N
H
OCO2H
O
O
CF3
 
MeN
N
H
N
H
OCO2H
O
O
OEt
MeN
N
H
N
H
OCO2H
O
O
CN
 
MeN
N
H
N
H
OCO2H
N
O
O
14{4,4} 
74% (>99%) 
14{4,5} 
68% (>99%) 
14{4,6} 
61% (77%)c 
14{4,7} 
62% (99%) 
14{4,8} 
54% (71%) 
MeN
N
H
N
H
OCO2H
N
Me  
MeN
N
H
N
H
OCO2H
N
CF3
Me  
MeN
N
H
N
H
OCO2H
N
OEt
Me
MeN
N
H
N
H
OCO2H
N
CN
Me  
MeN
N
H
N
H
OCO2H
N
N
Me
14{5,4} 
58% (14%)d 
14{5,5} 
65% (79%)e 
14{5,6} 
62% (16%)f 
14{5,7} 
61% (99%) 
14{5,8} 
56% (0%)g 
MeN
N
H
N
H
OCO2H
N
Me  
MeN
N
H
N
H
OCO2H
N
CF3
Me  
MeN
N
H
N
H
OCO2H
N
OEt
Me
MeN
N
H
N
H
OCO2H
N
CN
Me  
MeN
N
H
N
H
OCO2H
N
N
Me
14{6,4} 
79% (97%)h 
14{6,5} 
76% (>99%) 
14{6,6} 
70% (94%)i 
14{6,7} 
67% (99%) 
14{6,8} 
71% (36%) 
a % = Crude yield based on mass recovery; b (%) = Purity determined by LC-MS at 215 nm; c Plus 
5{4,6} (21%). d Plus 5{5,4} (77%); e Plus 5{5,5} (18%). f Plus 5{5,6} (81%); g Plus 5{5,8} (54%);  
h Plus 5{6,4} (2%); i Plus 5{6,6} (5%). 
In order to find conditions for the exclusive formation of the spiro dihydrouracils using aryl 
isocyanates, the α-ureidomethyl ester 15{1,4} was synthesized, isolated, and reacted with several 
bases under different conditions for the formation of spiro dihydrouracil 5{1,4} (Table 6). 
Firstly, the reaction was attempted with an easy-to-handle base because, if successful, it would 
make the work-up of the reactions easy—an important factor in parallel synthesis. All the amines used 
were found to have insufficient basicity for this transformation to take place (entries 1–5) [49–51]. The 
amidine DBU gave promising results, but the separation of the product 5{1,4} from DBU (and 
especially from the coreagent Bu4NBr, entry 8) was difficult and tedious, making these reaction 
conditions unsuitable for parallel synthesis [52,53]. Potassium tert-butoxide was the only base that 
caused >99% of the starting material to react [54], but it was the base that gave the largest amount of 
hydrolyzed product 14{1,4} (entries 9–12). Heating only (entry 15) resulted in decomposition of the 
starting material. To the best of our knowledge, there is no example in the literature of a dihydrouracil 
ring with such a tendency toward hydrolysis under basic conditions. This cyclization can also take 
place using acid catalysis [55-58], but this has not yet been attempted. 
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Table 6. Optimization of the formation of spiro dihydrouracil 5{1,4}. 
MeN
Ph
N
H
N
H
O
Ph
MeN
Ph
N
H
N
H
O
Ph
MeN
Ph
NH
NO O
Ph
+
15{1,4} 5{1,4} 14{1,4}
CO2Me CO2H
 
Entry Conditions Products
a 
15{1,4}/5{1,4}/14{1,4} 
1 Et3N (1.1 equiv), THF, Ar, reflux, 22 h 1:0:0 
2 Proton sponge (0.2 equiv), THF, 21 °C, 5 h 1:0:0 
3 Proton sponge (1 equiv), THF, 21 °C, 17 h 1:0:0 
4 Proton sponge (1 equiv), THF, reflux, 7 h 1:0:0 
5 DIPEA (1 equiv), DMF, 90 °C, 6 h 1:0:0 
6 DBU (1 equiv), THF, Ar, 26 °C, 5 h 1:0:0 
7 DBU (1 equiv), THF, Ar, reflux, 17 h 5:1:0 
8 DBU (1 equiv), Bu4NBr, 4 Å MS, PhMe, Ar, reflux, 27 h 1:9:0 
9 KOBut (1 equiv), THF, 29 °C, 30 min 1:3:1 
10 KOBut (1 equiv), THF, 31 °C, 55 min 0:2:1 
11 KOBut (1 equiv), THF, Ar, 21 °C, 2 h 0:1:2 
12 KOBut (0.1 equiv), THF, Ar, 21 °C, 17 h 3:6:1 
13 Phosphazene P2-t-Bu (0.1 equiv), THF, Ar, 21 °C, 5 h 1:3:0 
14 Phosphazene P2-t-Bu (1 equiv), THF, Ar, 21 °C, 18 h 1:0:4 
15 DMSO, 165 °C, 15 h decomposition 
a Ratio calculated by integration of the 1H-NMR signals of the crude reaction mixture. 
The compounds 5{1–6,1–3}, 5{1,4}, 6{1–6}, 14{1–6,4–8}, and 15{1,4} were tested on different 
CNS targets, but the results cannot be published because of the patent policy of the companies 
involved in the project. 
 
3. Experimental 
 
3.1. General 
Reagents were obtained from commercial suppliers and were used without purification. Solvents 
were distilled from appropriate drying agents prior to use and were stored under nitrogen. Reactions 
were followed, and RF values were obtained, using thin-layer chromatography (TLC) on silica gel-
coated plates (Merck 60 F254) with the indicated solvent mixture. Detection was performed with UV 
light and/or by charring at ca. 150 °C after dipping into a solution of KMnO4 or ninhydrin. Column or 
flash chromatography was carried out using ACROS silica gel (0.035–0.070 mm, pore diameter  
ca. 6 nm). IR spectra were recorded on an ATI Mattson Genesis Series FTIR spectrometer. High-
resolution mass spectra were recorded on a JEOL AccuTOF (ESI) or a MAT900 (EI, CI, and ESI). 
Low-resolution ESI mass spectra were recorded on a Thermo Finnigan LCQ Advantage Max Ion Trap 
mass spectrometer. Elemental analyses were carried out using a Carlo Erba Instruments CHNS-O EA 
1108 element analyzer. Melting points were analyzed with a Büchi melting point B-545 and are not 
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corrected. Gas chromatography (GC) was performed on a Hewlett Packard 5890, containing a HP1 
column (25 m x 0.32 mm x 0.17 μm), FID detection, and equipped with a HP3393A integrator. NMR 
spectra were recorded at 298 K on a Bruker DMX 300 (300 MHz) or a Varian 400 (400 MHz) 
spectrometer in the solvent indicated. Chemical shifts are given in parts per million (ppm) with respect 
to tetramethylsilane (0.00 ppm) or CD3SOCHD2 (2.50 ppm) as internal standard for 1H-NMR; and 
CDCl3 (77.16 ppm) or CD3SOCD3 (39.52 ppm) as internal standard for 13C-NMR [59]. Coupling 
constants are reported as J values in hertz (Hz). Multiplicity data are denoted by s (singlet), d (doublet), 
t (triplet), q (quartet), m (multiplet), b (broad), and app (apparent). Peak assignment in 13C spectra are 
based on 2D gHSQC and gHMBC spectra, and DEPT 135 when needed. Chain numbering 
corresponds to IUPAC nomenclature, so unprimed atoms belong to the principal chain, primed atoms 
belong to the first named substituent, doubled-primed atoms to the second named substituent, etc. LC-
MS measurements were run on a Shimadzu LC-10A VP series liquid chromatography system, 
equipped with an SPD-10A VP UV-vis detector and a LCMS-2010A mass spectrometer. The column 
used for the LC analysis was an Agilent Zorbax Extend C18 (3.5 μm, 4.6 × 150 mm), and it was eluted 
at 1 mL/min with a gradient made up of two solvent mixtures. Solvent A consisted of 0.1% 
trifluoroacetic acid in water and solvent B consisted of 0.1% trifluoroacetic acid in acetonitrile. The 
gradient was run as follows: t ) 0 min, 50% A; t ) 5 min, 5% A; t ) 10 min, 5% A; t ) 12.5 min, 50% A; 
t ) 20 min, 50% A. A wavelength of 215 nm was selected for the analysis of purity. 
3.2. General procedure for Knoevenagel condensation reaction 
Piperidine (5 drops) was added to a solution of methyl 2-cyanoacetate (9) and the aldehyde 10  
(1.0 equiv) in MeOH. The resulting reaction mixture was stirred at room temperature for the time 
indicated in each case. The reaction mixture was filtered and the precipitate was recrystalized from 
MeOH. The filtrate was concentrated under reduced pressure and purified by recrystalization from 
MeOH. 
Methyl (E)-2-cyano-3-phenylacrylate (8{1}): According to the general procedure, the reaction of 
methyl 2-cyanoacetate (9, 7.940 g, 80.13 mmol) with benzaldehyde 10{1} (8.504 g, 80.13 mmol) over 
30 min afforded 8{1} (14.910 g, 99%) as a white solid. 1H-NMR [400 MHz, δ (ppm), CDCl3]: 8.21 (s, 
1 1H, 3-CH), 7.97–7.92 (m, 2 1H, 2′-CH + 6′-CH), 7.56–7.43 (m, 3 1H, 3′-CH + 4′-CH + 5′-CH), 3.90 
(s, 3 1H, OCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 162.5 (CO2), 154.9 (3-C), 133.1 (4′-C), 131.1 
(1′-C), 130.8 (2′-C + 6′-C), 129.0 (3′-C + 5′-C), 115.2 (CN), 102.4 (2-C), 53.4 (OCH3). FTIR [
_ν  (cm–
1), neat]: 3036, 2954, 2224, 1727, 1606, 1200, 767, 685. Elem. anal. calcd. for C11H9NO2: C 70.58%, 
H 4.85%, N 7.48%; found C 70.39%, H 4.54%, N 7.43%. RF: 0.63 (heptane/AcOEt, 1:1). Mp: 87.9 °C 
(from MeOH, colorless flake-like crystals). Purity: >99.5% (GC). 
Methyl (E)-2-cyano-3-(4-methoxyphenyl)acrylate (8{2}): According to the general procedure, the 
reaction of methyl 2-cyanoacetate (9, 6.804 g, 68.66 mmol) with 4-methoxybenzaldehyde 10{2} 
(9.349 g, 68.66 mmol) over 30 min afforded 8{2} (14.020 g, 94%) as a white solid. 1H-NMR [400 
MHz, δ (ppm), CDCl3]: 8.14 (s, 1 1H, 3-CH), 8.00–7.95 (m, 2 1H, 2′-CH + 6′-CH), 7.01–6.95 (m, 2 1H, 
3′-CH + 5′-CH), 3.91 (s, 3 1H, CO2CH3), 3.88 (s, 3 1H, OCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 
163.8 (4′-C), 163.5 (CO2), 154.5 (3-C), 133.6 (2′-C + 6′-C), 124.2 (1′-C), 116.1 (CN), 114.7 (3′-C + 5′-
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C), 98.8 (2-C), 55.6 (OCH3), 53.1 (CO2CH3). FTIR [
_ν  (cm–1), neat]: 3084, 2954, 2846, 2215, 1714, 
1580, 1264, 1174, 841. Elem. anal. calcd. for C12H11NO3: C 66.35%, H 5.10%, N 6.45%; found C 
66.24%, H 4.98%, N 6.33%. RF: 0.58 (heptane/AcOEt, 1:1). Mp: 104.1 °C (from MeOH, off-white 
small crystals). Purity: >99.5% (GC). 
Methyl (E)-2-cyano-3-(3,5-dimethoxyphenyl)acrylate (8{3}): According to the general procedure, the 
reaction of methyl 2-cyanoacetate (9, 5.835 g, 58.89 mmol) with 3,5-dimethoxybenzaldehyde 10{3} 
(9.785 g, 58.89 mmol) over 40 min afforded 8{3} (12.399 g, 99%) as a yellow solid. 1H-NMR [400 
MHz, δ (ppm), CDCl3]: 8.17 (s, 1 1H, 3-CH), 7.15 (d, J = 2.4 Hz, 2 1H, 2′-CH + 6′-CH), 6.65 (t, J = 2.4 
Hz, 1 1H, 4′-CH), 3.94 (s, 3 1H, CO2CH3), 3.84 (s, 6 1H, 2 × OCH3). 13C-NMR [75 MHz, δ (ppm), 
CDCl3]: 163.1 (CO2), 161.2 (3′-C + 5′-C), 155.6 (3-C), 133.1 (1′-C), 115.6 (CN), 108.7 (2′-C + 6′-C), 
106.4 (4′-C), 103.0 (2-C), 55.8 (2 × OCH3), 53.6 (CO2CH3). FTIR [
_ν  (cm–1), neat]: 3086, 2940, 2841, 
2217, 1723, 1604, 1247, 1167, 840. Elem. anal. calcd for C13H13NO4: C 63.15%, H 5.30%, N 5.66%; 
found C 63.22%, H 5.14%, N 5.53%. RF: 0.56 (heptane/AcOEt, 1:1). Mp: 121.5 °C (from MeOH, long 
light yellow needles). Purity: >99.5% (GC). 
Methyl (E)-3-(1,3-benzodioxol-5-yl)-2-cyanoacrylate (8{4}): According to the general procedure, the 
reaction of methyl 2-cyanoacetate (9, 6.002 g, 60.57 mmol) with piperonal 10{4} (9.094 g, 60.57 
mmol) over 60 min afforded 8{4} (13.836 g, 99%) as a light greenish solid. 1H-NMR [400 MHz, δ 
(ppm), CDCl3]: 8.12 (s, 1 1H, 3-CH), 7.71 (d, J = 1.9 Hz, 1 1H, 4′-CH), 7.41 (ddd; J = 8.2, 1.9, 0.6 Hz; 
1 1H, 6′-CH), 6.91 (d, J = 8.2 Hz, 1 1H, 7′-CH), 6.09 (s, 2 1H, 2′-CH2), 3.92 (s, 3 1H, OCH3). 13C-NMR 
[75 MHz, δ (ppm), CDCl3]: 163.6 (CO2), 154.7 (3-C), 152.5 (7′a-C), 148.8 (3′a-C), 130.0 (6′-C), 126.1 
(5′-C), 116.1 (CN), 109.1 (4′-C), 109.0 (7′-C), 102.5 (2′-C), 99.5 (2-C), 53.4 (OCH3). FTIR [
_ν  (cm–1), 
neat]: 3029, 2957, 2218, 1723, 1579, 1244, 1205, 1041, 922, 819. HRMS [EI (m/z)] calcd for 
C12H9NO4 = 231.0532, found for [M+•] = 231.0532 (|Δ| = 0.0 ppm), peaks at (relative intensity): 231 
(100), 200 (21), 170 (32), 142 (12), 114 (21). Elem. anal. calcd for C12H9NO4: C 62.34%, H 3.92%, N 
6.06%; found C 62.24%, H 3.86%, N 6.00%. RF: 0.60 (heptane/AcOEt, 1:1). Mp: 169.6 °C (from 
MeOH, light green cotton-like solid). Purity: >99.5% (GC). 
Methyl (E)-2-cyano-3-(1-methyl-1H-pyrrol-2-yl)acrylate (8{5}): According to the general procedure, 
the reaction of methyl 2-cyanoacetate (9, 7.107 g, 71.72 mmol) with 1-methyl-1H-pyrrole-2-
carbaldehyde 10{5} (7.827 g, 71.72 mmol) over 120 min afforded 8{5} (12.932 g, 95%) as a yellow 
solid. 1H-NMR [400 MHz, δ (ppm), CDCl3]: 8.08 (s, 1 1H, 3-CH). 7.72 (d, J = 4.4 Hz, 1 1H, 3′-CH), 
7.01 (t, J = 1.8 Hz, 1 1H, 5′-CH), 6.39–6.36 (m, 1 1H, 4′-CH), 3.89 (s, 3 1H, OCH3), 3.78 (s, 3 1H, 
NCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 164.8 (CO2), 139.6 (3-C), 131.7 (5′-C), 127.5 (2′-C), 
120.0 (3′-C), 117.1(CN), 112.2 (4′-C), 92.8 (2-C), 53.0 (OCH3), 34.4 (NCH3). FTIR [
_ν  (cm–1), neat]: 
3120, 2957, 2899, 2210, 1717, 1591, 1243, 748. Elem. anal. calcd for C10H10N2O2: C 63.15%, H 
5.30%, N 14.73%; found C 63.19%, H 5.09%, N 14.70%. RF: 0.29 (heptane/AcOEt, 1:1). Mp: 154.2 
°C (from MeOH, yellow solid). Purity: >99.5% (GC). 
Methyl (E)-2-cyano-3-(1-methyl-1H-indol-3-yl)acrylate (8{6}): According to the general procedure, 
the reaction of methyl 2-cyanoacetate (9, 6.011 g, 60.66 mmol) with 1-methyl-1H-indole-3-
carbaldehyde 10{6} (9.656 mg, 60.66 mmol) over 120 min afforded 8{6} (13.977 g, 96%) as a yellow 
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solid. 1H- NMR [400 MHz, δ (ppm), CDCl3]: 8.56 (s, 1 1H, 3-CH), 8.49 (s, 1 1H, 2′-CH), 7.84–7.80 
(m, 1 1H, 4′-CH), 7.42–7.31 (m, 3 1H, 5′-CH + 6′-CH + 7′-CH), 3.91 (s, 3 1H, CO2CH3), 3.90 (s, 3 1H, 
NCH3). 13C- NMR [75 MHz, δ (ppm), CDCl3]: 164.6 (CO2), 146.2 (3-C), 137.0 (7′a-C), 134.9 (2′-C), 
128.5 (3′a-C), 124.1 (6′-C), 122.8 (5′-C), 118.6 (4′-C), 118.5 (CN), 110.6 (7′-C), 110.1 (3′-C), 93.3 (2-
C), 52.9 (OCH3), 34.2 (NCH3). FTIR [
_ν  (cm–1), neat]: 3118, 3026, 2950, 2222, 1701, 1586, 1255, 751. 
HRMS [EI (m/z)] calcd for C14H12N2O2 = 240.0899, found for [M+•] = 240.0895 (|Δ| = 1.6 ppm), peaks 
at (relative intensity): 240 (100), 209 (53), 140 (18), 49 (12). Elem. anal. calcd for C14H12N2O2: C 
69.99%, H 5.03%, N 11.66%; found C 69.69%, H 4.85%, N 11.42%. RF: 0.37 (heptane/AcOEt, 1:1). 
Mp: 165.9 °C (from MeOH, yellow solid). Purity: >99.5% (GC). 
Methyl (E)-2-cyano-3-(1H-pyrrol-2-yl)acrylate (8{7}): According to the general procedure, the 
reaction of methyl 2-cyanoacetate (9, 991 mg, 10.00 mmol) with 1H-pyrrole-2-carbaldehyde 10{7} 
(951 mg, 10.00 mmol) over 30 min afforded 8{7} (1.744 g, 99%) as a yellow solid. 1H-NMR [400 
MHz, δ (ppm), CDCl3]: 9.92 (bs, 1 1H, NH), 8.02 (s, 1 1H, 3-CH), 7.26–7.23 (m, 1 1H, 5′-CH), 6.98–
6.94 (m, 1 1H, 3′-CH), 6.44 (dt; J = 3.9, 2.3 Hz; 1 1H, 4′-CH), 3.89 (s, 3 1H, OCH3). 13C-NMR [75 
MHz, δ (ppm), CDCl3]: 164.2 (CO2), 142.8 (3-C), 128.4 (5′-C), 127.0 (2′-C), 124.7 (3′-C), 118.6 (CN), 
112.7 (4′-C), 91.8 (2-C), 53.0 (OCH3). FTIR [
_ν  (cm–1), neat]: 3300, 3032, 2950, 2215, 1692, 1593, 
1221, 750. Elem. anal. calcd for C9H8N2O2: C 61.36%, H 4.58%, N 15.90%; found C 61.45%, H 
4.58%, N 15.79%. RF: 0.37 (heptane/AcOEt, 1:1). Mp: 140.2 °C (from MeOH, small thin yellow 
needles). Purity: >99.5% (GC). 
Methyl (E)-2-cyano-3-(1H-indol-3-yl)acrylate (8{8}): According to the general procedure, the reaction 
of methyl 2-cyanoacetate (9, 991 mg, 10.00 mmol) with 1H-indole-3-carbaldehyde 10{8} (1.452 g, 
10.00 mmol) in THF (15 mL) over 480 min afforded 8{8} (2.239 g, 99%) as a yellow solid. 1H-NMR 
[400 MHz, δ (ppm), CD3SOCD3]: 12.64 (bs, 1 1H, NH), 8.64 (s, 1 1H, 2′-CH), 8.63 (s, 1 1H, 3-CH), 
8.05–7.99 (m, 1 1H, 4′-CH), 7.67–7.63 (m, 1 1H, 7′-CH), 7.41–7.30 (m, 2 1H, 5′-CH + 6′-CH), 3.92 (s, 
3 1H, OCH3). 13C-NMR [75 MHz, δ (ppm), CD3SOCD3]: 163.3 (CO2), 146.3 (3-C), 135.9 (7′a-C), 
132.4 (2′-C), 126.6 (3′a-C), 123.3 (6′-C), 121.9 (5′-C), 118.3 (4′-C), 117.8 (CN), 112.7 (7′-C), 109.7 
(3′-C), 91.8 (2-C), 52.6 (OCH3). FTIR [
_ν  (cm–1), neat]: 3266, 3132, 2989, 2943, 2212, 1695, 1589, 
1241, 742. Elem. anal. calcd for C13H10N2O2: C 69.02%, H 4.46%, N 12.38%; found C 68.97%, H 
4.38%, N 12.22%. RF: 0.80 (AcOEt). Mp: 189.5 °C (from MeOH, yellow needles). Purity: >99.5% 
(GC). 
Methyl (E)-2-cyano-3-(2-thienyl)acrylate (8{9}): According to the general procedure, the reaction of 
methyl 2-cyanoacetate (9, 991 mg, 10.00 mmol) with thiophene-2-carbaldehyde 10{9} (1.121 g, 10.00 
mmol) over 30 min afforded 8{9} (1.816 g, 94%) as a light brown solid. 1H-NMR [400 MHz, δ (ppm), 
CDCl3]: 8.36 (s, 1 1H, 3-CH), 7.84 (d, J = 3.9 Hz, 1 1H, 3′-CH), 7.80 (d, J = 4.9 Hz, 1 1H, 5′-CH), 7.24 
(dd; J = 4.9, 3.9 Hz; 1 1H, 4′-CH), 3.92 (s, 3 1H, OCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 162.9 
(CO2), 146.7 (3-C), 137.2 (3′-C), 135.8 (2′-C), 135.2 (5′-C), 128.6 (4′-C), 115.6 (CN), 98.8 (2-C), 53.4 
(OCH3). FTIR [
_ν  (cm–1), neat]: 3087, 3028, 2964, 2216, 1718, 1590, 1271, 1214, 729. Elem. anal. 
calcd for C9H7NO2S: C 55.94%, H 3.65%, N 7.25%; found C 55.98%, H 3.63%, N 7.23%. RF: 0.61 
(heptane/AcOEt, 1:1). Mp: 106.9 °C (from MeOH, light brown needles). Purity: >99.5% (GC). 
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Methyl (E)-2-cyano-3-(2-pyridyl)acrylate (8{10}): According to the general procedure, the reaction of 
methyl 2-cyanoacetate (9, 991 mg, 10.00 mmol) with pyridine-2-carbaldehyde 10{10} (1.071 g, 10.00 
mmol) over 30 min afforded 8{10} (1.863 g, 99%) as a brown solid. 1H-NMR [400 MHz, δ (ppm), 
CDCl3]: 8.83 (ddd; J = 4.8, 1.6, 1.0 Hz; 1 1H, 6′-CH), 8.30 (s, 1 1H, 3-CH), 7.89 (app dt; J = 7.8, 1.2 
Hz; 1 1H, 3′-CH), 7.85 (app dt; J = 1.6, 7.8 Hz; 1 1H, 4′-CH), 7.44 (ddd; J = 7.3, 4.9, 1.5 Hz; 1 1H, 5′-
CH), 3.96 (s, 3 1H, OCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 162.6 (CO2), 153.7 (3-C), 150.7 (6′-
C), 150.0 (2′-C), 137.1 (4′-C), 126.8 (5′-C), 126.4 (3′-C), 114.8 (CN), 106.4 (2-C), 53.7 (OCH3). FTIR 
[
_ν  (cm–1), neat]: 3050, 2963, 2220, 1720, 1278, 1215, 781, 740. Elem. anal. calcd for C10H8N2O2: C 
63.83%, H 4.28%, N 14.89%; found C 64.06%, H 4.26%, N 14.79%. RF: 0.34 (heptane/AcOEt, 1:1). 
Mp: 131.7 °C (from MeOH, small brown needles). Purity: >99.5% (GC). 
Methyl (E)-2-cyano-3-(3-pyridyl)acrylate (8{11}): According to the general procedure, the reaction of 
methyl 2-cyanoacetate (9, 991 mg, 10.00 mmol) with pyridine-3-carbaldehyde 10{11} (1.071 g, 10.00 
mmol) over 90 min afforded 8{11} (1.750 g, 93%) as a light yellow dust. 1H-NMR [300 MHz, δ 
(ppm), CDCl3]: 8.91 (d, J = 1.8 Hz, 1 1H, 2′-CH), 8.74 (dd; J = 4.8, 1.8 Hz; 1 1H, 6′-CH), 8.57–8.51 
(m, 1 1H, 4′-CH), 8.26 (s, 1 1H, 3-CH), 7.46 (dd; J = 7.8, 4.8 Hz; 1 1H, 5′-CH), 3.95 (s, 3 1H, OCH3). 
13C-NMR [75 MHz, δ (ppm), CDCl3]: 161.9 (CO2), 153.3 (3-C), 152.7 (6′-C), 151.3 (2′-C), 135.8 (4′-
C), 127.3 (3′-C), 123.9 (5′-C), 114.7 (CN), 105.1 (2-C), 53.8 (OCH3). FTIR [
_ν  (cm–1), neat]: 3031, 
2959, 2223, 1722, 1280, 697. RF: 0.13 (heptane/AcOEt, 1:1). Mp: 129.2 °C. 
Methyl (E)-2-cyano-3-(4-pyridyl)acrylate (8{12}): According to the general procedure, the reaction of 
methyl 2-cyanoacetate (9, 991 mg, 10.00 mmol) with pyridine-4-carbaldehyde 10{12} (1.071 g, 10.00 
mmol) over 25 min afforded 8{12} (1.863 g, 99%) as a pink solid. 1H-NMR [400 MHz, δ (ppm), 
CDCl3]: 8.86–8.80 (m, 2 1H, 2′-CH + 6′-CH), 8.23 (s, 1 1H, 3-CH), 7.80–7.74 (m, 2 1H, 3′-CH + 5′-
CH), 3.97 (s, 3 1H, OCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 161.8 (CO2), 152.4 (3-C), 151.2 (2′-
C + 6′-C), 138.0 (4′-C), 123.3 (3′-C + 5′-C), 114.2 (CN), 107.8 (2-C), 53.8 (OCH3). FTIR [
_ν  (cm–1), 
neat]: 3033, 2955, 2225, 1726, 1236, 1198, 818. Elem. anal. calcd for C10H8N2O2: C 63.83%, H 
4.28%, N 14.89%; found C 63.94%, H 4.25%, N 14.75%. RF: 0.12 (heptane/AcOEt, 1:1). Mp:  
126.6 °C (from MeOH, small pink needles). Purity: >99.5% (GC). 
3.3. General procedure for 1,3-dipolar cycloaddition reactions of 8 
A round-bottomed flask fitted with a Dean–Stark apparatus, a reflux condenser, and a drying tube 
containing calcium chloride was charged with 2-cyanoacrylate 8 and toluene (0.20–0.25 M). When the 
mixture was under reflux, sarcosine (N-methylglycine; 1.2 equiv) and paraformaldehyde (3.6 equiv) 
were added. This addition was repeated every 40 min until the substrate had completely reacted. Water 
(20 mL) was then added and the layers were separated. The aqueous layer was extracted with Et2O  
(3 × 30 mL) and the combined organic layers were dried (MgSO4), filtered, and concentrated in vacuo. 
(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-phenylpyrrolidine-3-carboxylate (7{1}): According to the 
general procedure, 2-cyanoacrylate 8{1} (5.342 g, 28.54 mmol) afforded 7{1} (6.524 g, 94%) as a 
white solid, after column chromatography (heptane/AcOEt, 3:1→2:1). 1H-NMR [400 MHz, δ (ppm), 
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CDCl3]: 7.33–7.19 (m, 5 1H, Ph), 4.00 (app t, J = 7.8 Hz, 1 1H, 4-CH), 3.70 (s, 3 1H, OCH3), 3.25 (d, J 
= 9.9 Hz, 1 1H, 2-CHH), 3.18 (d, J = 9.9 Hz, 1 1H, 2-CHH), 3.04 (dd; J = 9.6, 7.8 Hz; 1 1H, 5-CHH), 
3.00 (dd; J = 9.6, 8.1 Hz; 1 1H, 5-CHH), 2.38 (s, 3 1H, NCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 
167.6 (CO2), 136.6 (1′-C), 128.0 (2′-C + 6′-C), 127.9 (3′-C + 5′-C), 127.5 (4′-C), 117.2 (CN), 64.9 (2-
C), 60.2 (5-C), 54.4 (3-C), 53.5 (CO2CH3), 51.8 (4-C), 41.1 (NCH3). FTIR [
_ν  (cm–1), neat]: 2950, 
2846, 2790, 2241, 1740, 1247, 772, 699. MS [ESI (m/z)] calcd for (C14H16N2O2 + H)+ = 245, found 
245. RF: 0.24 (heptane/AcOEt, 1:1). Mp: 53.3 °C (from heptane, colorless crystals). Purity: >99.5% 
(GC). 
(±)-Methyl (3R,4R)-3-cyano-4-(4-methoxyphenyl)-1-methylpyrrolidine-3-carboxylate (7{2}): 
According to the general procedure, 2-cyanoacrylate 8{2} (6.162 g, 28.37 mmol) afforded 7{2} (7.688 
g, 99%) as a yellow oil. 1H-NMR [400 MHz, δ (ppm), CDCl3]: 7.28–7.22 (m, 2 1H, 2′-CH + 6′-CH), 
6.87–6.82 (m, 2 1H, 3′-CH + 5′-CH), 3.98 (app t, J = 8.0 Hz, 1 1H, 4-CH), 3.80 (s, 3 1H, CO2CH3), 3.76 
(s, 3 1H, OCH3), 3.31 (d, J = 9.9 Hz, 1 1H, 2-CHH), 3.20 (d, J = 9.9 Hz, 1 1H, 2-CHH), 3.07 (dd; J = 
9.6, 7.8 Hz; 1 1H, 5-CHH), 3.02 (dd; J = 9.6, 8.1 Hz; 1 1H, 5-CHH), 2.44 (s, 3 1H, NCH3). 13C-NMR 
[75 MHz, δ (ppm), CDCl3]: 168.1 (CO2), 159.1 (4′-C), 129.4 (2′-C + 6′-C), 128.6 (1′-C), 117.8 (CN), 
113.8 (3′-C + 5′-C), 65.2 (2-C), 60.8 (5-C), 55.2 (OCH3), 54.9 (3-C), 53.9 (CO2CH3), 51.8 (4-C), 41.6 
(NCH3). FTIR [
_ν  (cm–1), neat]: 2951, 2836, 2788, 2243, 1740, 1247, 832. MS [ESI (m/z)] calcd for 
(C15H18N2O3 + H)+ = 275, found 275. RF: 0.23 (heptane/AcOEt, 1:1). Purity: 98.9% (GC). 
(±)-Methyl (3R,4R)-3-cyano-4-(3,5-dimethoxyphenyl)-1-methylpyrrolidine-3-carboxylate (7{3}): 
According to the general procedure, 2-cyanoacrylate 8{3} (9.745 g, 39.41 mmol) afforded 7{3} 
(11.398 g, 95%) as a white solid, after column chromatography (heptane/AcOEt, 3:1→2:1). 1H-NMR 
[400 MHz, δ (ppm), CDCl3]: 6.51 (d, J = 2.2 Hz, 2 1H, 2′-CH + 6′-CH), 6.41 (t, J = 2.2 Hz, 1 1H, 4′-
CH), 3.99 (app t, J = 7.9 Hz, 1 1H, 4-CH), 3.84 (s, 3 1H, CO2CH3), 3.78 (s, 6 1H, 2 × OCH3), 3.30 (d, J 
= 9.9 Hz, 1 1H, 2-CHH), 3.24 (d, J = 9.9 Hz, 1 1H, 2-CHH), 3.09 (dd; J = 9.6, 7.8 Hz; 1 1H, 5-CHH), 
3.06 (dd; J = 9.6, 8.0 Hz; 1 1H, 5-CHH), 2.47 (s, 3 1H, NCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 
168.8 (CO2), 161.1 (3′-C + 5′-C), 139.4 (1′-C), 118.1 (CN), 107.0 (2′-C + 6′-C), 100.2 (4′-C), 65.7 (2-
C), 60.7 (5-C), 55.6 (2 × OCH3), 54.8 (3-C), 54.2 (CO2CH3), 52.6 (4-C), 41.8 (NCH3). FTIR [
_ν  (cm–
1), neat]: 2948, 2837, 2790, 2243, 1743, 1595, 1203, 1155. HRMS [EI (m/z)] calcd for C16H20N2O4 = 
304.1423, found for [M+•] = 304.1436 (|Δ| = 4.2 ppm), peaks at (relative intensity): 304 (16), 261 (18), 
193 (11), 57 (100), 42 (20). Elem. anal. calcd for C16H20N2O4: C 63.14%, H 6.62%, N 9.20%; found C 
63.33%, H 6.65%, N 9.19%. RF: 0.19 (heptane/AcOEt, 1:1). Mp: 94.7 °C (from heptane, colorless 
crystals). Purity: >99.5% (GC). 
(±)-Methyl (3R,4R)-4-(1,3-benzodioxol-5-yl)-3-cyano-1-methylpyrrolidine-3-carboxylate (7{4}): 
According to the general procedure, 2-cyanoacrylate 8{4} (9.774 g, 42.27 mmol) afforded 7{4} 
(12.041 g, 99%) as a white solid. 1H-NMR [400 MHz, δ (ppm), CDCl3]: 6.88 (d, J = 1.7 Hz, 1 1H, 4′-
CH), 6.81 (dd; J = 8.0, 1.7 Hz; 1 1H, 6′-CH), 6.77 (d, J = 8.0 Hz, 1 1H, 7′-CH), 5.95 (d, J = 1.6 Hz, 1 
1H, 2′-CHH), 5.94 (d, J = 1.6 Hz, 1 1H, 2′-CHH), 3.97 (t, J = 7.8 Hz, 1 1H, 4-CH), 3.84 (s, 3 1H, 
OCH3), 3.28 (d, J = 9.9 Hz, 1 1H, 2-CHH), 3.23 (d, J = 9.9 Hz, 1 1H, 2-CHH), 3.06 (dd; J = 9.5, 7.8 
Hz; 1 1H, 5-CHH), 3.01 (dd; J = 9.5, 7.8 Hz; 1 1H, 5-CHH), 2.45 (s, 3 1H, NCH3). 13C-NMR [75 MHz, 
δ (ppm), CDCl3]: 168.5 (CO2), 147.9 (3′a-C), 147.5 (7′a-C), 130.8 (5′-C), 122.0 (6′-C), 117.9 (CN), 
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108.8 (7′-C), 108.3 (4′-C), 101.2 (2′-C), 65.3 (2-C), 60.8 (5-C), 54.8 (3-C), 54.0 (OCH3), 52.1 (4-C), 
41.5 (NCH3). FTIR [
_ν  (cm–1), neat]: 2965, 2900, 2788, 2242, 1740, 1249, 1036, 929. HRMS [EI 
(m/z)] calcd for C15H16N2O4 = 288.1110, found for [M+•] = 288.1097 (|Δ| = 4.5 ppm), peaks at (relative 
intensity): 288 (13), 57 (100), 42 (11). Elem. anal. calcd for C15H16N2O4: C 62.49%, H 5.59%, N 
9.72%; found C 62.56%, H 5.61%, N 9.69%. RF: 0.22 (heptane/AcOEt, 1:1). Mp: 87.6 °C (from 
heptane, colorless crystals). Purity: >99.5% (GC). 
(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-(1-methyl-1H-pyrrol-2-yl)pyrrolidine-3-carboxylate (7{5}): 
According to the general procedure, 2-cyanoacrylate 8{5} (1.132 g, 5.95 mmol) afforded 7{5} (765 
mg, 52%) as a yellow oil, after column chromatography (heptane/AcOEt, 3:1→2:1). 1H-NMR [400 
MHz, δ (ppm), CDCl3]: 6.62 (dd; J = 2.7, 1.7 Hz; 1 1H, 5′-CH), 6.28 (dd; J = 3.6, 1.7 Hz; 1 1H, 3′-CH), 
6.14 (dd; J = 3.6, 2.7 Hz; 1 1H, 4′-CH), 4.25 (app t, J = 8.2 Hz, 1 1H, 4-CH), 3.87 (s, 3 1H, OCH3), 3.57 
(s, 3 1H, 1′-NCH3), 3.45 (d, J = 9.9 Hz, 1 1H, 2-CHH), 3.26 (dd; J = 9.5, 7.6 Hz; 1 1H, 5-CHH), 3.04 
(d, J = 9.9 Hz, 1 1H, 2-CHH), 2.84 (app t, J = 9.1 Hz, 1 1H, 5-CHH), 2.44 (s, 3 1H, 1-NCH3). 13C-NMR 
[75 MHz, δ (ppm), CDCl3]: 168.9 (CO2), 128.2 (2′-C), 123.5 (5′-C), 117.2 (CN), 108.7 (4′-C), 107.6 
(3′-C), 65.2 (2-C), 61.3 (5-C), 54.2 (OCH3), 53.8 (3-C), 43.7 (4-C), 41.5 (1-NCH3), 34.0 (1′-NCH3). 
FTIR [
_ν  (cm–1), neat]: 2951, 2888, 2791, 2242, 1741, 1241, 717. MS [ESI (m/z)] calcd for 
(C13H17N3O2 + H)+ = 248, found 248. RF: 0.23 (heptane/AcOEt, 1:1). Purity: 98.2% (GC). 
(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-(1-methyl-1H-indol-3-yl)pyrrolidine-3-carboxylate (7{6}): 
According to the general procedure, 2-cyanoacrylate 8{6} (9.241 g, 38.46 mmol) afforded 7{6} 
(10.831 g, 95%) as a yellow solid, after column chromatography (heptane/AcOEt, 3:1→2:1). 1H-NMR 
[400 MHz, δ (ppm), CDCl3]: 7.50 (dt; J = 8.1, 1.0 Hz; 1 1H, 4′-CH), 7.29 (dt; J = 8.3, 1.0 Hz; 1 1H, 7′-
CH), 7.22 (ddd; J = 8.3, 7.1, 1.0 Hz; 1 1H, 6′-CH), 7.19 (s, 1 1H, 2′-CH), 7.10 (ddd; J = 8.1, 7.0, 1.0 
Hz; 1 1H, 5′-CH), 4.43 (dd; J = 9.6, 7.5 Hz; 1 1H, 4-CH), 3.76 (s, 3 1H, OCH3), 3.74 (s, 3 1H, 1′-NCH3), 
3.51 (d, J = 10.2 Hz, 1 1H, 2-CHH), 3.25 (d, J = 10.2 Hz, 1 1H, 2-CHH), 3.23 (dd; J = 9.6, 7.5 Hz; 1 
1H, 5-CHH), 3.08 (t, J = 9.6 Hz, 1 1H, 5-CHH), 2.51 (s, 3 1H, 1-NCH3). 13C-NMR [75 MHz, δ (ppm), 
CDCl3]: 169.0 (CO2), 136.8 (7′a-C), 127.7 (3′a-C), 127.4 (2′-C), 122.1 (6′-C), 119.5 (5′-C), 118.7 (4′-
C), 118.5 (CN), 109.63 (3′-C), 109.58 (7′-C), 65.3 (2-C), 60.9 (5-C), 55.1 (3-C), 53.9 (OCH3), 45.2 (4-
C), 42.0 (1-NCH3), 33.0 (1′-NCH3). FTIR [
_ν  (cm–1), neat]: 3045, 2948, 2842, 2786, 2243, 1741, 1474, 
1243, 742. HRMS [EI (m/z)] calcd for C17H19N3O2 = 297.1477, found for [M+•] = 297.1467 (|Δ| = 3.5 
ppm), peaks at (relative intensity): 297 (17), 144 (16), 57 (100), 42 (21). RF: 0.17 (heptane/AcOEt, 
1:1). Mp: 92.6 °C. Purity: 98.8% (GC). 
(±)-Methyl (3R,4R)-3-cyano-4-{1-[(dimethylamino)methyl]-1H-indol-3-yl}-1-methylpyrrolidine-3-
carboxylate (7{13}): According to the general procedure, 2-cyanoacrylate 8{8} (1.512 g, 6.68 mmol) 
afforded 7{13} (1.929 g, 85%) as a yellow solid. 1H-NMR [300 MHz, δ (ppm), CDCl3]: 7.45 (d, J = 
7.8 Hz, 1 1H, 4′-CH), 7.36 (d, J = 8.1 Hz, 1 1H, 7′-CH), 7.24 (s, 1 1H, 2′-CH), 7.14 (ddd; J = 8.1, 6.9, 
1.0 Hz; 1 1H, 6′-CH), 7.05 (ddd; J = 7.8, 6.9, 1.0 Hz; 1 1H, 5′-CH), 4.69 (d, J = 12.9 Hz, 1 1H, 
NCHHN), 4.58 (d, J = 12.9 Hz, 1 1H, NCHHN), 4.40 (dd; J = 9.3, 7.6 Hz; 1 1H, 4-CH), 3.67 (s, 3 1H, 
OCH3), 3.43 (d, J = 10.0 Hz, 1 1H, 2-CHH), 3.17 (d, J = 10.0 Hz, 1 1H, 2-CHH), 3.16 (dd; J = 9.3, 7.6 
Hz; 1 1H, 5-CHH), 3.04 (t, J = 9.3 Hz, 1 1H, 5-CHH), 2.42 (s, 3 1H, 1-NCH3), 2.23 (s, 6 1H, N(CH3)2). 
13C-NMR [75 MHz, δ (ppm), CDCl3]: 168.5 (CO2), 136.7 (7′a-C), 127.5 (3′a-C), 126.9 (2′-C), 121.9 
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(6′-C), 119.4 (5′-C), 118.3 (4′-C), 118.0 (CN), 110.21 (3′-C), 110.17 (7′-C), 68.6 (NCH2N), 65.3 (2-C), 
60.7 (5-C), 55.1 (3-C), 53.8 (OCH3), 44.8 (4-C), 42.7 (N(CH3)2), 41.8 (NCH3). FTIR [
_ν  (cm–1), neat]: 
3049, 2942, 2842, 2778, 2242, 1740, 1460, 1239, 729. Elem. anal. calcd for C19H24N4O2: C 67.04%, H 
7.11%, N 16.46%; found C 66.98%, H 7.05%, N 16.18%. RF: 0.19 (AcOEt). Mp: 105.8 °C. 
(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-(2-thienyl)pyrrolidine-3-carboxylate (7{9}): According to the 
general procedure, 2-cyanoacrylate 8{9} (720 mg, 3.73 mmol) afforded 7{9} (814 mg; 87%, combined 
yield including 11{9}) as a yellow oil, after column chromatography (heptane/AcOEt, 1:1). 1H-NMR 
[300 MHz, δ (ppm), CDCl3]: 7.23 (dd; J = 5.1, 1.0 Hz; 1 1H, 5′-CH), 7.04 (dt; J = 3.6, 1.0 Hz; 1 1H, 3′-
CH), 6.98 (dd; J = 5.1, 3.6 Hz; 1 1H, 4′-CH), 4.32 (app t, J = 7.8 Hz, 1 1H, 4-CH), 3.85 (s, 3 1H, 
OCH3), 3.40 (d, J = 9.9 Hz, 1 1H, 2-CHH), 3.24 (dd; J = 9.6, 7.2 Hz; 1 1H, 5-CHH), 3.17 (d, J = 9.9 
Hz, 1 1H, 2-CHH), 3.00 (dd; J = 9.6, 8.4 Hz; 1 1H, 5-CHH), 2.46 (s, 3 1H, NCH3). MS [ESI (m/z)] 
calcd for (C12H14N2O2S + H)+ = 251, found 251. RF: 0.31 (heptane/AcOEt, 1:1). Purity: 97.6% (GC). 
(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-(2-pyridyl)pyrrolidine-3-carboxylate (7{10}): According to 
the general procedure, 2-cyanoacrylate 8{10} (1.006 g, 5.35 mmol) afforded a 6.5:1 mixture of 
7{10}/11{10} (1.182 g; 90%, combined yield) as a white solid, after column chromatography 
(CH2Cl2/MeOH, 24:1). (Measured from a 6.5:1 mixture of 7{10}/11{10}) 1H-NMR [400 MHz, δ 
(ppm), CDCl3]: 8.61 (d, J = 4.8 Hz, 1 1H, 6′-CH), 7.68 (app dt; J = 1.8, 7.6 Hz; 1 1H, 4′-CH), 7.30 (d, J 
= 7.8 Hz, 1 1H, 3′-CH), 6.91 (ddd; J = 7.6, 4.8, 0.7 Hz; 1 1H, 5′-CH), 4.30 (t, J = 8.0 Hz, 1 1H, 4-CH), 
3.88 (s, 3 1H, OCH3), 3.38 (d, J = 9.6 Hz, 1 1H, 2-CHH), 3.28 (dd; J = 9.3, 8.0 Hz; 1 1H, 5-CHH), 3.26 
(d, J = 9.6 Hz, 1 1H, 2-CHH), 3.22 (dd; J = 9.3, 8.0 Hz; 1 1H, 5-CHH), 2.49 (s, 3 1H, NCH3). MS [ESI 
(m/z)] calcd for (C13H15N3O2 + H)+ = 246, found 246. RF: 0.07 (heptane/AcOEt, 1:1). 
(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-(3-pyridyl)pyrrolidine-3-carboxylate (7{11}): According to 
the general procedure, 2-cyanoacrylate 8{11} (2.969 g, 15.78 mmol) afforded a 6.6:1 mixture of 
7{11}/11{11} (2.782 g; 72%, combined yield) as a light yellow sticky solid, after column 
chromatography (CH2Cl2/MeOH, 29:1). (Measured from a 6.6:1 mixture of 7{11}/11{11}) 1H-NMR 
[400 MHz, δ (ppm), CDCl3]: 8.56 (dd; J = 4.9, 1.7 Hz; 1 1H, 6′-CH), 8.56–8.54 (m, 1 1H, 2′-CH), 7.81 
(app dt; J = 8.0, 2.0 Hz; 1 1H, 4′-CH), 7.33 (ddd; J = 8.0, 4.9, 0.5 Hz; 1 1H, 5′-CH), 4.06 (app t, J = 7.7 
Hz, 1 1H, 4-CH), 3.84 (s, 3 1H, OCH3), 3.32 (d, J = 10.0 Hz, 1 1H, 2-CHH), 3.28 (d, J = 10.0 Hz, 1 1H, 
2-CHH), 3.09 (dd; J = 9.5, 7.8 Hz; 1 1H, 5-CHH), 3.06 (dd; J = 9.5, 7.6 Hz; 1 1H, 5-CHH), 2.47 (s, 3 
1H, NCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 168.0 (CO2), 150.1 (2′-C), 149.65 (6′-C), 135.9 (4′-
C), 133.2 (3′-C), 123.5 (5′-C), 117.6 (CN), 65.1 (2-C), 60.6 (5-C), 54.4 (3-C), 54.1 (CO2CH3), 49.4 (4-
C), 41.3 (NCH3). MS [ESI (m/z)] calcd for (C13H15N3O2 + H)+ = 246, found 246. RF: 0.10 
(heptane/AcOEt, 1:1). 
(±)-Methyl (3R,4S)-3-cyano-1-methyl-4-(3-pyridyl)pyrrolidine-3-carboxylate (11{11}): According to 
the general procedure, 2-cyanoacrylate 8{11} (2.969 g, 15.78 mmol) afforded a 6.6:1 mixture of 
7{11}/11{11} (2.782 g; 72%, combined yield) as a light yellow sticky solid, after column 
chromatography (CH2Cl2/MeOH, 29:1). (Measured from a 6.6:1 mixture of 7{11}/11{11}) 1H-NMR 
[400 MHz, δ (ppm), CDCl3]: 8.56–8.54 (m, 1 1H, 2′-CH), 8.53 (dd; J = 4.9, 1.7 Hz; 1 1H, 6′-CH), 7.69 
(app dt; J = 8.0, 2.0 Hz; 1 1H, 4′-CH), 7.25 (ddd; J = 8.0, 4.9, 0.5 Hz; 1 1H, 5′-CH), 4.07–4.04 (m, 1 
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1H, 4-CH), 3.40 (d, J = 10.2 Hz, 1 1H, 2-CHH), 3.35 (d, J = 10.2 Hz, 1 1H, 2-CHH), 3.27 (s, 3 1H, 
OCH3), 3.09 (dd; J = 9.3, 6.6 Hz; 1 1H, 5-CHH), 2.97 (dd; J = 9.3, 8.6 Hz; 1 1H, 5-CHH), 2.51 (s, 3 1H, 
NCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 166.6 (CO2), 150.0 (2′-C), 149.60 (6′-C), 135.9 (4′-C), 
131.9 (3′-C), 123.2 (5′-C), 120.2 (CN), 63.4 (2-C), 59.6 (5-C), 53.4 (4-C), 53.1 (CO2CH3), 52.4 (3-C), 
41.2 (NCH3). RF: 0.10 (heptane/AcOEt, 1:1). 
(±)-Methyl (3R,4R)-3-cyano-1-methyl-4-(4-pyridyl)pyrrolidine-3-carboxylate (7{12}): According to 
the general procedure, 2-cyanoacrylate 8{12} (1.037 g, 5.51 mmol) afforded a 5:1 mixture of 
7{12}/11{12} (1.145 g; 85%, combined yield) as a light yellow oil, after column chromatography 
(CH2Cl2/MeOH, 24:1). (Measured from a 5:1 mixture of 7{12}/11{12}) 1H-NMR [400 MHz, δ (ppm), 
CDCl3]: 8.62–8.58 (m, 2 1H, 2′-CH + 6′-CH), 7.32–7.28 (m, 2 1H, 3′-CH + 5′-CH), 4.03 (app t, J = 7.6 
Hz, 1 1H, 4-CH), 3.86 (s, 3 1H, OCH3), 3.32 (d, J = 10.0 Hz, 1 1H, 2-CHH), 3.26 (d, J = 10.0 Hz, 1 1H, 
2-CHH), 3.09 (dd; J = 9.8, 7.2 Hz; 1 1H, 5-CHH), 3.06 (dd; J = 9.8, 7.8 Hz; 1 1H, 5-CHH), 2.47 (s, 3 
1H, NCH3). MS [ESI (m/z)] calcd for (C13H15N3O2 + H)+ = 246, found 246. RF: 0.06 (heptane/AcOEt, 
1:1). 
3.4. General procedure for reduction 
An excess (7–8 heaped teaspoons) of freshly washed (with MeOH) Raney nickel was added to a 
solution of α-cyano ester 7 with Et3N (ca. 1 equiv) in MeOH (0.25–0.30 M). The mixture was stirred 
for 15 h at room temperature under a hydrogen atmosphere (1 atm). The catalyst was separated by 
filtration with suction through a glass filter with a 0.5 cm layer of diatomaceous earth. The catalyst 
was washed thoroughly with MeOH. The combined methanolic solutions were concentrated on a 
rotary evaporator. 
(±)-Methyl (3R,4S)-3-(aminomethyl)-1-methyl-4-phenylpyrrolidine-3-carboxylate (6{1}): According to 
the general procedure, α-cyano ester 7{1} (5.040 g, 20.63 mmol) afforded 6{1} (4.858 g, 95%) as a 
colorless oil. 1H-NMR [200 MHz, δ (ppm), CDCl3]: 7.36–7.21 (m, 5 1H, Ph), 3.93 (dd; J = 8.6, 7.3 Hz; 
1 1H, 4-CH), 3.79 (s, 3 1H, OCH3), 3.35 (d, J = 9.6 Hz, 1 1H, 2-CHH), 3.08 (dd; J = 9.2, 7.3 Hz; 1 1H, 
5-CHH), 2.77 (app t, J = 9.0 Hz, 1 1H, 5-CHH), 2.62 (d, J = 13.0 Hz, 1 1H, CHHNH2), 2.52 (d,  
J = 13.0 Hz, 1 1H, CHHNH2), 2.48 (d, J = 9.6 Hz, 1 1H, 2-CHH), 2.41 (s, 3 1H, NCH3), 1.78 (bs, 2 1H, 
NH2). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 175.9 (CO2), 138.4 (1′-C), 128.7 (2′-C + 6′-C), 127.9 (3′-
C + 5′-C), 126.6 (4′-C), 64.0 (2-C), 61.6 (5-C), 58.6 (3-C), 52.2 (CO2CH3), 49.9 (4-C), 46.7 
(CH2NH2), 42.2 (NCH3). FTIR [
_ν  (cm–1), neat]: 3386, 3028, 2946, 2781, 1727, 1601, 1455, 1174, 772, 
703. HRMS [ESI (m/z)] calcd for (C14H20N2O2 + H)+ = 249.16030, found 249.15963 (|Δ| = 2.71 ppm). 
RF: 0.30 (CH2Cl2/MeOH, 8:1). Purity: 99.1% (GC). 
(±)-Methyl (3R,4S)-3-(aminomethyl)-4-(4-methoxyphenyl)-1-methylpyrrolidine-3-carboxylate (6{2}): 
According to the general procedure, α-cyano ester 7{2} (6.997 g, 25.51 mmol) afforded 6{2} (6.731 g, 
95%) as a colorless oil. 1H-NMR [400 MHz, δ (ppm), CDCl3]: 7.27–7.23 (m, 2 1H, 2′-CH + 6′-CH), 
6.86–6.82 (m, 2 1H, 3′-CH + 5′-CH), 3.88 (app t, J = 8.0 Hz, 1 1H, 4-CH), 3.79 (s, 3 1H, CO2CH3), 3.78 
(s, 3 1H, OCH3), 3.33 (d, J = 9.9 Hz, 1 1H, 2-CHH), 3.06 (dd; J = 8.8, 7.8 Hz; 1 1H, 5-CHH), 2.71 (app 
t, J = 8.9 Hz, 1 1H, 5-CHH), 2.63 (d, J = 13.2 Hz, 1 1H, CHHNH2), 2.52 (d, J = 13.2 Hz, 1 1H, 
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CHHNH2), 2.46 (d, J = 9.9 Hz, 1 1H, 2-CHH), 2.40 (s, 3 1H, NCH3), 0.92 (bs, 2 1H, NH2). 13C-NMR 
[75 MHz, δ (ppm), CDCl3]: 176.1 (CO2), 158.2 (4′-C), 130.3 (1′-C), 129.7 (2′-C + 6′-C), 113.5 (3′-C + 
5′-C), 64.1 (2-C), 61.8 (5-C), 58.6 (3-C), 55.2 (OCH3), 52.3 (CO2CH3), 49.2 (4-C), 46.8 (CH2NH2), 
42.3 (NCH3). FTIR [
_ν  (cm–1), neat]: 3383, 3222, 2947, 2834, 2779, 1724, 1247, 834. HRMS [ESI 
(m/z)] calcd for (C15H22N2O3 + H)+ = 279.17087, found 279.17006 (|Δ| = 2.87 ppm). RF: 0.27 
(CH2Cl2/MeOH, 8:1). Purity: 98.1% (GC). 
(±)-Methyl (3R,4S)-3-(aminomethyl)-4-(3,5-dimethoxyphenyl)-1-methylpyrrolidine-3-carboxylate 
(6{3}): According to the general procedure, α-cyano ester 7{3} (7.452 g, 25.06 mmol) afforded 6{3} 
(6.730 g, 89%) as a yellow oil, after column chromatography (CH2Cl2/MeOH, 9:1). 1H-NMR [400 
MHz, δ (ppm), CDCl3]: 6.51 (d, J = 2.2 Hz, 2 1H, 2′-CH + 6′-CH), 6.35 (t, J = 2.2 Hz, 1 1H, 4′-CH), 
3.87 (app t, J = 7.9 Hz, 1 1H, 4-CH), 3.80 (s, 3 1H, CO2CH3), 3.78 (s, 6 1H, 2 × OCH3), 3.31 (d, J = 9.8 
Hz, 1 1H, 2-CHH), 3.06 (dd; J = 9.0, 7.8 Hz; 1 1H, 5-CHH), 2.72 (app t, J = 8.8 Hz, 1 1H, 5-CHH), 
2.71 (d, J = 13.0 Hz, 1 1H, CHHNH2), 2.58 (d, J = 13.0 Hz, 1 1H, CHHNH2), 2.48 (d, J = 9.8 Hz, 1 1H, 
2-CHH), 2.40 (s, 3 1H, NCH3), 1.45 (bs, 2 1H, NH2). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 176.5 
(CO2), 160.6 (3′-C + 5′-C), 141.2 (1′-C), 107.5 (2′-C + 6′-C), 98.6 (4′-C), 64.2 (2-C), 61.6 (5-C), 58.7 
(3-C), 55.3 (2 × OCH3), 52.4 (CO2CH3), 50.0 (4-C), 46.6 (CH2NH2), 42.3 (NCH3). FTIR [
_ν  (cm–1), 
neat]: 3380, 3188, 2942, 2835, 2781, 1723, 1593, 1203, 1152. HRMS [ESI (m/z)] calcd for 
(C16H24N2O4 + H)+ = 309.18143, found 309.18062 (|Δ| = 2.62 ppm). RF: 0.30 (CH2Cl2/MeOH, 8:1). 
Purity: 98.2% (GC). 
(±)-Methyl (3R,4S)-3-(aminomethyl)-4-(1,3-benzodioxol-5-yl)-1-methylpyrrolidine-3-carboxylate 
(6{4}): According to the general procedure, α-cyano ester 7{4} (7.009 g, 24.31 mmol) afforded 6{4} 
(6.055 g, 85%) as a light yellow oil, after column chromatography (CH2Cl2/MeOH, 9:1). 1H-NMR 
[400 MHz, δ (ppm), CDCl3]: 6.88 (d, J = 1.7 Hz, 1 1H, 4′-CH), 6.78 (dd; J = 8.1, 1.5 Hz; 1 1H, 6′-CH), 
6.72 (d, J = 8.1 Hz, 1 1H, 7′-CH), 5.92 (s, 2 1H, 2′-CH2), 3.83 (app t, J = 7.7 Hz, 1 1H, 4-CH), 3.78 (s, 3 
1H, OCH3), 3.27 (d, J = 9.9 Hz, 1 1H, 2-CHH), 3.01 (dd; J = 9.3, 7.6 Hz; 1 1H, 5-CHH), 2.67 (app t, J 
= 8.7 Hz, 1 1H, 5-CHH), 2.66 (d, J = 12.9 Hz, 1 1H, CHHNH2), 2.53 (d, J = 12.9 Hz, 1 1H, CHHNH2), 
2.48 (d, J = 9.9 Hz, 1 1H, 2-CHH), 2.38 (s, 3 1H, NCH3), 1.01 (bs, 2 1H, NH2). 13C-NMR [75 MHz, δ 
(ppm), CDCl3]: 176.3 (CO2), 147.4 (3′a-C), 146.3 (7′a-C), 132.5 (5′-C), 122.0 (6′-C), 109.3 (4′-C), 
107.8 (7′-C), 100.8 (2′-C), 63.8 (2-C), 61.8 (5-C), 58.6 (3-C), 52.1 (OCH3), 49.5 (4-C), 46.6 
(CH2NH2), 42.0 (NCH3). FTIR [
_ν  (cm–1), neat]: 3320, 3317, 2946, 2841, 2776, 1721, 1248, 1232, 
1034, 929. HRMS [ESI (m/z)] calcd for (C15H20N2O4 + H)+ = 293.15013, found 293.14936 (|Δ| = 2.63 
ppm). RF: 0.25 (CH2Cl2/MeOH, 8:1). Purity: 97.4% (GC). 
(±)-Methyl (3R,4S)-3-(aminomethyl)-1-methyl-4-(1-methyl-1H-pyrrol-2-yl)pyrrolidine-3-carboxylate 
(6{5}): According to the general procedure, α-cyano ester 7{5} (752 mg, 3.04 mmol) afforded 6{5} 
(559 mg, 73%) as a light yellow oil, after column chromatography (CH2Cl2/MeOH, 9:1). 1H-NMR 
[400 MHz, δ (ppm), CDCl3]: 6.54 (dd; J = 2.4, 1.8 Hz; 1 1H, 5′-CH), 6.07 (dd; J = 3.6, 2.7 Hz; 1 1H, 
4′-CH), 6.04 (dd; J = 3.8, 1.7 Hz; 1 1H, 3′-CH), 4.10 (dd; J = 10.5, 7.2 Hz; 1 1H, 4-CH), 3.78 (s, 3 1H, 
OCH3), 3.60 (s, 3 1H, 1′-NCH3), 3.39 (d, J = 9.9 Hz, 1 1H, 2-CHH), 3.19 (app t, J = 8.2 Hz, 1 1H, 5-
CHH), 2.72 (d, J = 13.2 Hz, 1 1H, CHHNH2), 2.62 (d, J = 13.2 Hz, 1 1H, CHHNH2), 2.47 (app t,  
J = 9.8 Hz, 1 1H, 5-CHH), 2.35 (s, 3 1H, 1-NCH3), 2.21 (d, J = 9.9 Hz, 1 1H, 2-CHH), 1.35 (bs, 2 1H, 
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NH2). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 177.1 (CO2), 129.8 (2′-C), 122.3 (5′-C), 107.8 (3′-C), 
107.3 (4′-C), 65.3 (2-C), 62.5 (5-C), 58.4 (3-C), 52.5 (OCH3), 46.7 (CH2NH2), 42.2 (1-NCH3), 40.9 (4-
C), 34.2 (1′-NCH3). FTIR [
_ν  (cm–1), neat]: 3390, 3099, 2946, 2839, 2780, 1729, 1242, 712. HRMS 
[ESI (m/z)] calcd for (C13H21N3O2 + H)+ = 252.17120, found 252.17083 (|Δ| = 1.49 ppm). RF: 0.24 
(CH2Cl2/MeOH, 8:1). Purity: 97.7% (GC). 
(±)-Methyl (3R,4S)-3-(aminomethyl)-1-methyl-4-(1-methyl-1H-indol-3-yl)pyrrolidine-3-carboxylate 
(6{6}): According to the general procedure, α-cyano ester 7{6} (7.628 g, 25.65 mmol) afforded 6{6} 
(7.337 g, 95%) as a yellow oil, after column chromatography (CH2Cl2/MeOH, 9:1). 1H-NMR [400 
MHz, δ (ppm), CDCl3]: 7.72 (dt; J = 8.0, 1.0 Hz; 1 1H, 4′-CH), 7.28 (dt; J = 8.0, 1.0 Hz; 1 1H, 7′-CH), 
7.21 (ddd; J = 8.0, 6.8, 1.0 Hz; 1 1H, 6′-CH), 7.11 (ddd; J = 8.0, 6.8, 1.0 Hz; 1 1H, 5′-CH), 6.98 (s, 1 
1H, 2′-CH), 4.32 (dd; J = 9.3, 7.3 Hz; 1 1H, 4-CH), 3.83 (s, 3 1H, OCH3), 3.76 (s, 3 1H, 1′-NCH3), 3.43 
(d, J = 10.0 Hz, 1 1H, 2-CHH), 3.17 (dd; J = 9.3, 7.3 Hz; 1 1H, 5-CHH), 2.75 (d, J = 13.2 Hz, 1 1H, 
CHHNH2), 2.68 (t, J = 9.3 Hz, 1 1H, 5-CHH), 2.60 (d, J = 13.2 Hz, 1 1H, CHHNH2), 2.45 (d, J = 10.0 
Hz, 1 1H, 2-CHH), 2.42 (s, 3 1H, 1-NCH3), 1.04 (bs, 2 1H, NH2). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 
177.1 (CO2), 136.9 (7′a-C), 128.3 (3′a-C), 127.3 (2′-C), 122.0 (6′-C), 119.9 (5′-C), 119.3 (4′-C), 112.0 
(3′-C), 109.3 (7′-C), 64.8 (2-C), 62.5 (5-C), 58.4 (3-C), 52.4 (OCH3), 47.1 (CH2NH2), 42.5 (4-C), 41.6 
(1-NCH3), 32.9 (1′-NCH3). FTIR [
_ν  (cm–1), neat]: 3386, 3047, 2946, 2834, 2779, 1720, 1472, 1172, 
741. HRMS [EI (m/z)] calcd for C17H23N3O2 = 301.1790, found for [M+•] = 301.1776 (|Δ| = 4.7 ppm), 
peaks at (relative intensity): 301 (7), 284 (93), 228 (18), 157 (100), 144 (22), 57 (27). RF: 0.22 
(CH2Cl2/MeOH, 8:1). Purity: 98.0% (GC). 
(±)-(3R,4R)-3-Cyano-1-methyl-4-phenylpyrrolidine-3-carboxamide (12{1}): 1H-NMR [300 MHz, δ 
(ppm), CDCl3]: 7.41–7.26 (m, 5 1H, Ph), 6.58 (s, 1 1H, NHH), 6.40 (s, 1 1H, NHH), 3.99 (app t, J = 8.1 
Hz, 1 1H, 4-CH), 3.34 (d, J = 9.8 Hz, 1 1H, 2-CHH), 3.16 (app t, J = 8.7 Hz, 1 1H, 5-CHH), 3.12 (d,  
J = 9.8 Hz, 1 1H, 2-CHH), 3.03 (app t, J = 8.9 Hz, 1 1H, 5-CHH), 2.47 (s, 3 1H, NCH3). 13C-NMR [75 
MHz, δ (ppm), CDCl3]: 169.4 (CON), 137.1 (1′-C), 128.6 (2′-C + 6′-C), 128.4 (3′-C + 5′-C), 128.2 (4′-
C), 119.0 (CN), 65.2 (2-C), 60.9 (5-C), 55.9 (3-C), 53.1 (4-C), 41.6 (NCH3). FTIR [
_ν  (cm–1), neat]: 
3334, 3192, 2950, 2846, 2794, 2241, 1684, 772, 698. Elem. anal. calcd for C13H15N3O: C 68.11%, H 
6.59%, N 18.33%; found C 68.10%, H 6.48%, N 18.13%. RF: 0.40 (AcOEt). Mp: 121.7 °C (from 
propan-2-ol, small white needles). Purity: >99.5% (GC). 
3.5. Parallel synthesis 
3.5.1. General procedure 1 for spiro dihydrouracil/α-ureidomethyl acid formation using parallel 
synthesis 
A solution of isocyanate 13 (0.12 mmol for 1, 0.10 mmol for 3–5) from a 0.3 M stock solution in 
CH2Cl2 was added to a solution of α-aminomethyl ester (0.10 mmol) in CH2Cl2 (1.5 mL). The 
resulting reaction mixture was stirred at room temperature for 15 h. After that time, the solvent was 
evaporated and THF (1.5 mL) and 1 M KOBut in THF (0.10 mmol) were added. The reaction mixture 
was then stirred at room temperature for 15 h. A saturated solution of NH4Cl (1.0 mL) was added and 
the layers were separated (centrifugation was needed for the separation when aryl isocyanate was 
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used). The aqueous layer was extracted with CH2Cl2 (2 × 1.5 mL) and the combined organic layers 
were evaporated to dryness under vacuum. 
3.5.2. General procedure 2 for spiro dihydrouracil/α-ureidomethyl acid formation using parallel 
synthesis 
A solution of isocyanate 13{2,6–8} (0.10 mmol) from a 0.3 M stock solution in DMF was added to 
a solution of α-aminomethyl ester (0.10 mmol) in DMF (1.5 mL). The resulting reaction mixture was 
stirred at 80 °C for 15 h. After that time, the solvent was evaporated and THF (1.5 mL) and 1 M 
KOBut in THF (0.10 mmol) were added. The reaction mixture was then stirred at room temperature for 
15 h. A saturated solution of NH4Cl (1.0 mL) was added and the layers were separated (centrifugation 
was needed for the separation when aryl isocyanate was used). The aqueous layer was extracted with 
CH2Cl2 (2 × 1.5 mL) and the combined organic layers were evaporated to dryness under vacuum. 
(±)-(4R,5S)-7-Ethyl-2-methyl-4-phenyl-2,7,9-triazaspiro[4.5]decane-6,8-dione (5{1,1}): (From 6{1}) 
1H-NMR [400 MHz, δ (ppm), CDCl3]: 7.30–7.19 (m, 5 1H, Ph), 5.60 (bd, J = 2.1 Hz, 1 1H, NH), 4.20 
(dd; J = 8.1, 5.4 Hz; 1 1H, 4-CH), 3.85 (dq; J = 12.9, 7.2 Hz; 1 1H, CHHCH3), 3.80 (dq; J = 12.9, 7.2 
Hz; 1 1H, CHHCH3), 3.06 (dd; J = 9.6, 5.4 Hz; 1 1H, 3-CHH), 2.99 (dd; J = 9.6, 8.1 Hz; 1 1H, 3-CHH), 
2.95 (d, J = 9.3 Hz, 1 1H, 1-CHH), 2.94 (dd; J = 12.6, 4.2 Hz; 1 1H, 10-CHH), 2.68 (d, J = 9.3 Hz, 1 
1H, 1-CHH), 2.66 (d, J = 12.6 Hz, 1 1H, 10-CHH), 2.41 (s, 3 1H, NCH3), 1.16 (t, J = 7.2 Hz, 3 1H, 
CH2CH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 173.1 (6-C), 154.1 (8-C), 139.4 (1′-C), 128.7 (2′-C + 
6′-C), 128.6 (3′-C + 5′-C), 127.3 (4′-C), 64.0 (1-C), 62.0 (3-C), 52.0 (5-C), 48.3 (4-C), 43.4 (10-C), 
42.0 (NCH3), 36.4 (CH2CH3), 13.8 (CH2CH3). FTIR [
_ν  (cm–1), neat]: 3240, 2937, 2841, 2784, 1716, 
1673, 763, 703. MS [APCI (m/z)] calcd for (C16H21N3O2 + H)+ = 288, found 288. Crude yield: 51%. 
Purity: 89% (LC). 
(±)-(4R,5S)-2-Methyl-7-phenethyl-4-phenyl-2,7,9-triazaspiro[4.5]decane-6,8-dione (5{1,2}): (From 
6{1}) 1H-NMR [400 MHz, δ (ppm), CDCl3]: 7.33–7.15 (m, 10 1H, 2 × Ph), 5.66 (bd, J = 3.4 Hz, 1 1H, 
NH), 4.16 (dd; J = 8.0, 5.4 Hz; 1 1H, 4-CH), 4.04 (dt; J = 13.0, 7.6 Hz; 1 1H, NCHHCH2), 3.98 (dt; J = 
13.0, 7.6 Hz; 1 1H, NCHHCH2), 3.05 (dd; J = 9.3, 5.4 Hz; 1 1H, 3-CHH), 2.98–2.83 (m, 5 1H, 1-CHH 
+ 3-CHH + 10-CHH + NCH2CH2), 2.56 (d, J = 9.5 Hz, 1 1H, 1-CHH), 2.55 (d, J = 13.2 Hz, 1 1H, 10-
CHH), 2.39 (s, 3 1H, NCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 173.2 (6-C), 154.0 (8-C), 139.3 
(1′′-C), 138.6 (1′-C), 129.2 (2′-C + 6′-C), 128.8 (2′′-C + 6′′-C), 128.6 (3′′-C + 5′′-C), 128.5 (3′-C + 5′-
C), 127.3 (4′′-C), 126.5 (4′-C), 64.0 (1-C), 61.9 (3-C), 52.1 (5-C), 48.2 (4-C), 43.4 (10-C), 42.2 
(NCH2CH2), 41.9 (NCH3), 34.5 (NCH2CH2). FTIR [
_ν  (cm–1), neat]: 3254, 2938, 2841, 2784, 1717, 
1673, 758, 701. MS [APCI (m/z)] calcd for (C22H25N3O2 + H)+ = 364, found 364. Crude yield: 63%. 
Purity: 70% (LC). 
(±)-Ethyl 3-{(4R,5S)-2-methyl-6,8-dioxo-4-phenyl-2,7,9-triazaspiro[4.5]decan-7-yl}propanoate 
(5{1,3}): (From 6{1}) MS [APCI (m/z)] calcd for (C19H25N3O4 + H)+ = 360, found 360. Crude yield: 
80% (combined yield of 5{1,3}, 5{1,9}, 5{1,10}, and 5{1,11}). Purity: 91% (LC; combined purity of 
5{1,3}, 5{1,9}, 5{1,10}, and 5{1,11}). 
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(±)-(4R,5S)-7-Ethyl-4-(4-methoxyphenyl)-2-methyl-2,7,9-triazaspiro[4.5]decane-6,8-dione (5{2,1}): 
(From 6{2}) MS [APCI (m/z)] calcd for (C17H23N3O3 + H)+ = 318, found 318. Crude yield: 60%. 
Purity: 93% (LC). 
 
(±)-(4R,5S)-4-(4-Methoxyphenyl)-2-methyl-7-phenethyl-2,7,9-triazaspiro[4.5]decane-6,8-dione 
(5{2,2}): (From 6{2}) MS [APCI (m/z)] calcd for (C23H27N3O3 + H)+ = 394, found 394. Crude yield: 
64%. Purity: 60% (LC). 
(±)-Ethyl 3-{(4R,5S)-4-(4-methoxyphenyl)-2-methyl-6,8-dioxo-2,7,9-triazaspiro[4.5]decan-7-yl}prop-
anoate (5{2,3}): (From 6{2}) FTIR [
_ν  (cm–1), neat]: 3245, 2935, 2837, 2784, 1719, 1674, 1247, 835. 
MS [APCI (m/z)] calcd for (C20H27N3O5 + H)+ = 390, found 390. Crude yield: 49% (combined yield of 
5{2,3}, 5{2,9}, 5{2,10}, and 5{2,11}). Purity: 88% (LC; combined purity of 5{2,3}, 5{2,9}, 5{2,10}, 
and 5{2,11}). 
(±)-(4R,5S)-4-(3,5-Dimethoxyphenyl)-7-ethyl-2-methyl-2,7,9-triazaspiro[4.5]decane-6,8-dione 5{3,1}): 
(From 6{3}) MS [APCI (m/z)] calcd for (C18H25N3O4 + H)+ = 348, found 348. Crude yield: 66%. 
Purity: 90% (LC). 
(±)-(4R,5S)-4-(3,5-Dimethoxyphenyl)-2-methyl-7-phenethyl-2,7,9-triazaspiro[4.5]decane-6,8-dione  
5{3,2}): (From 6{3}) MS [APCI (m/z)] calcd for (C24H29N3O4 + H)+ = 424, found 424. Crude yield: 
60%. Purity: 68% (LC). 
(±)-Ethyl 3-{(4R,5S)-4-(3,5-dimethoxyphenyl)-2-methyl-6,8-dioxo-2,7,9-triazaspiro[4.5]decan-7-yl}-
propanoate (5{3,3}): (From 6{3}) MS [APCI (m/z)] calcd for (C21H29N3O6 + H)+ = 420, found 420. 
Crude yield: 54% (combined yield of 5{3,3}, 5{3,9}, 5{3,10}, and 5{3,11}). Purity: 95% (LC; 
combined purity of 5{3,3}, 5{3,9}, 5{3,10}, and 5{3,11}). 
(±)-(4R,5S)-4-(1,3-Benzodioxol-5-yl)-7-ethyl-2-methyl-2,7,9-triazaspiro[4.5]decane-6,8-dione  
(5{4,1}): (From 6{4}) MS [APCI (m/z)] calcd for (C17H21N3O4 + H)+ = 332, found 332. Crude yield: 
63%. Purity: 95% (LC). 
(±)-(4R,5S)-4-(1,3-Benzodioxol-5-yl)-2-methyl-7-phenethyl-2,7,9-triazaspiro[4.5]decane-6,8-dione 
 5{4,2}): (From 6{4}) MS [APCI (m/z)] calcd for (C23H25N3O4 + H)+ = 408, found 408. Crude yield: 
64%. Purity: 68% (LC). 
(±)-Ethyl 3-{(4R,5S)-4-(1,3-benzodioxol-5-yl)-2-methyl-6,8-dioxo-2,7,9-triazaspiro[4.5]decan-7-yl}-
propanoate (5{4,3}): (From 6{4}) MS [APCI (m/z)] calcd for (C20H25N3O6 + H)+ = 404, found 404. 
Crude yield: 61% (combined yield of 5{4,3}, 5{4,9}, 5{4,10}, and 5{4,11}). Purity: 98% (LC; 
combined purity of 5{4,3}, 5{4,9}, 5{4,10}, and 5{4,11}). 
(±)-(4R,5S)-7-Ethyl-2-methyl-4-(1-methyl-1H-pyrrol-2-yl)-2,7,9-triazaspiro[4.5]decane-6,8-dione  
(5{5,1}): (From 6{5}) 1H-NMR [400 MHz, δ (ppm), CDCl3]: 6.52 (dd; J = 2.8, 1.6 Hz; 1 1H, 5′-CH), 
6.05 (dd; J = 3.5, 2.8 Hz; 1 1H, 4′-CH), 6.03 (dd; J = 3.5, 1.6 Hz; 1 1H, 3′-CH), 5.84 (bd, J = 3.5 Hz, 1 
1H, NH), 4.35 (app t, J = 8.0 Hz, 1 1H, 4-CH), 3.85 (dq; J = 13.1, 7.0 Hz; 1 1H, CHHCH3), 3.79 (dq; J 
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= 13.1, 7.0 Hz; 1 1H, CHHCH3), 3.44 (s, 3 1H, 1′-NCH3), 3.15 (app t, J = 8.6 Hz, 1 1H, 3-CHH), 2.96 
(dd; J = 13.0, 4.6 Hz; 1 1H, 10-CHH), 2.92 (d, J = 9.8 Hz, 1 1H, 1-CHH), 2.78 (app t, J = 8.8 Hz, 1 1H, 
3-CHH), 2.65 (d, J = 9.8 Hz, 1 1H, 1-CHH), 2.62 (d, J = 13.0 Hz, 1 1H, 10-CHH), 2.37 (s, 3 1H, 2-
NCH3), 1.15 (t, J = 7.0 Hz, 3 1H, CH2CH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 173.5 (6-C), 154.2 
(8-C), 129.9 (2′-C), 122.4 (5′-C), 107.5 (3′-C), 107.2 (4′-C), 66.0 (1-C), 62.0 (3-C), 51.0 (5-C), 43.9 
(10-C), 41.9 (2-NCH3), 39.5 (4-C), 36.4 (CH2CH3), 34.1 (1′-NCH3), 13.7 (CH2CH3). FTIR [
_ν  (cm–1), 
neat]: 3329, 2937, 2842, 2784, 1716, 1671, 727. MS [APCI (m/z)] calcd for (C15H22N4O2 + H)+ = 291, 
found 291. Crude yield: 61%. Purity: 99% (LC). 
(±)-(4R,5S)-2-Methyl-4-(1-methyl-1H-pyrrol-2-yl)-7-phenethyl-2,7,9-triazaspiro[4.5]decane-6,8-dione 
(5{5,2}): (From 6{5}) 1H-NMR [400 MHz, δ (ppm), CDCl3]: 7.32–7.15 (m, 5 1H, Ph), 6.51 (dd; J = 
2.8, 1.6 Hz; 1 1H, 5′-CH), 6.05 (dd; J = 3.5, 2.8 Hz; 1 1H, 4′-CH), 6.02 (dd; J = 3.5, 1.6 Hz; 1 1H, 3′-
CH), 5.96 (bd, J = 4.0 Hz, 1 1H, NH), 4.31 (app t, J = 8.1 Hz, 1 1H, 4-CH), 4.08–3.95 (m, 2 1H, 
NCH2CH2), 3.34 (s, 3 1H, 1′-NCH3), 3.13 (app t, J = 8.6 Hz, 1 1H, 3-CHH), 2.92 (dd; J = 12.9, 4.7 Hz; 
1 1H, 10-CHH), 2.91–2.83 (m, 2 1H, NCH2CH2), 2.80 (d, J = 9.8 Hz, 1 1H, 1-CHH), 2.76 (app t, J = 
8.8 Hz, 1 1H, 3-CHH), 2.62 (d, J = 9.8 Hz, 1 1H, 1-CHH), 2.55 (d, J = 12.9 Hz, 1 1H, 10-CHH), 2.35 
(s, 3 1H, 2-NCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 173.6 (6-C), 154.2 (8-C), 138.6 (1′′-C), 
129.8 (2′-C), 129.2 (2′′-C + 6′′-C), 128.5 (3′′-C + 5′′-C), 126.5 (4′′-C), 122.4 (5′-C), 107.5 (3′-C), 107.2 
(4′-C), 65.9 (1-C), 62.0 (3-C), 51.0 (5-C), 43.8 (10-C), 42.2 (NCH2CH2), 41.9 (2-NCH3), 39.3 (4-C), 
34.4 (NCH2CH2), 34.1 (1′-NCH3). FTIR [
_ν  (cm–1), neat]: 3251, 2941, 2843, 2785, 1716, 1671, 761, 
728, 699. MS [APCI (m/z)] calcd for (C21H26N4O2 + H)+ = 367, found 367. Crude yield: 54%. Purity: 
92% (LC). 
(±)-Ethyl 3-{(4R,5S)-2-methyl-4-(1-methyl-1H-pyrrol-2-yl)-6,8-dioxo-2,7,9-triazaspiro[4.5]decan-7-
yl}propanoate (5{5,3}): (From 6{5}) MS [APCI (m/z)] calcd for (C18H26N4O4 + H)+ = 363, found 363. 
Crude yield: 66% (combined yield of 5{5,3}, 5{5,9}, 5{5,10}, and 5{5,11}). Purity: 79% (LC; 
combined purity of 5{5,3}, 5{5,9}, 5{5,10}, and 5{5,11}). 
(±)-(4R,5S)-7-Ethyl-2-methyl-4-(1-methyl-1H-indol-3-yl)-2,7,9-triazaspiro[4.5]decane-6,8-dione  
(5{6,1}): (From 6{6}) MS [APCI (m/z)] calcd for (C19H24N4O2 + H)+ = 341, found 341. Crude yield: 
69%. Purity: 69% (LC). 
(±)-(4R,5S)-2-Methyl-4-(1-methyl-1H-indol-3-yl)-7-phenethyl-2,7,9-triazaspiro[4.5]decane-6,8-dione  
(5{6,2}): (From 6{6}) MS [APCI (m/z)] calcd for (C25H28N4O2 + H)+ = 417, found 417. Crude yield: 
68%. Purity: 62% (LC). 
(±)-Ethyl 3-{(4R,5S)-2-methyl-4-(1-methyl-1H-indol-3-yl)-6,8-dioxo-2,7,9-triazaspiro[4.5]decan-7-
yl}-propanoate (5{6,3}): (From 6{6}) MS [APCI (m/z)] calcd for (C22H28N4O4 + H)+ = 413, found 
413. Crude yield: 62% (combined yield of 5{6,3}, 5{6,9}, 5{6,10}, and 5{6,11}). Purity: 86% (LC; 
combined purity of 5{6,3}, 5{6,9}, 5{6,10}, and 5{6,11}). 
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(±)-(3R,4S)-1-Methyl-4-phenyl-3-[(3-phenylureido)methyl]pyrrolidine-3-carboxylic acid (14{1,4}): 
(From 6{1}) MS [APCI (m/z)] calcd for (C20H23N3O3 + H)+ = 354, found 354. Crude yield: 49%. 
Purity: >99% (LC). 
(±)-(3R,4S)-1-Methyl-4-phenyl-3-({3-[4-(trifluoromethyl)phenyl]ureido}methyl)pyrrolidine-3-carboxy-
lic acid (14{1,5}): (From 6{1}) MS [APCI (m/z)] calcd for (C21H22F3N3O3 + H)+ = 422, found 422. 
Crude yield: 75%. Purity: 97% (LC). 
(±)-(3R,4S)-3-{[3-(4-Ethoxyphenyl)ureido]methyl}-1-methyl-4-phenylpyrrolidine-3-carboxylic acid 
(14{1,6}): (From 6{1}) MS [APCI (m/z)] calcd for (C22H27N3O4 + H)+ = 398, found 398. Crude yield: 
48%. Purity: >99% (LC). 
(±)-(3R,4S)-3-{[3-(3-Cyanophenyl)ureido]methyl}-1-methyl-4-phenylpyrrolidine-3-carboxylic acid 
(14{1,7}): (From 6{1}) MS [APCI (m/z)] calcd for (C21H22N4O3 + H)+ = 379, found 379. Crude yield: 
54%. Purity: >99% (LC). 
(±)-(3R,4S)-1-Methyl-4-phenyl-3-{[3-(3-pyridyl)ureido]methyl}pyrrolidine-3-carboxylic acid 
(14{1,8}): (From 6{1}) MS [APCI (m/z)] calcd for (C19H22N4O3 + H)+ = 355, found 355. Crude yield: 
49%. Purity: 79% (LC). 
(±)-(3R,4S)-4-(4-Methoxyphenyl)-1-methyl-3-[(3-phenylureido)methyl]pyrrolidine-3-carboxylic acid 
(14{2,4}): (From 6{2}) MS [APCI (m/z)] calcd for (C21H25N3O4 + H)+ = 384, found 384. Crude yield: 
60%. Purity: 99% (LC). 
(±)-(3R,4S)-4-(4-Methoxyphenyl)-1-methyl-3-({3-[4-(trifluoromethyl)phenyl]ureido}methyl)-pyrroli-
dine-3-carboxylic acid (14{2,5}): (From 6{2}) MS [APCI (m/z)] calcd for (C22H24F3N3O4 + H)+ = 
452, found 452. Crude yield: 65%. Purity: 98% (LC). 
(±)-(3R,4S)-3-{[3-(4-Ethoxyphenyl)ureido]methyl}-4-(4-methoxyphenyl)-1-methylpyrrolidine-3-car- 
boxylic acid (14{2,6}): (From 6{2}) MS [APCI (m/z)] calcd for (C23H29N3O5 + H)+ = 428, found 428. 
Crude yield: 70%. Purity: >99% (LC). 
(±)-(3R,4S)-3-{[3-(3-Cyanophenyl)ureido]methyl}-4-(4-methoxyphenyl)-1-methylpyrrolidine-3-car- 
boxylic acid (14{2,7}): (From 6{2}) MS [APCI (m/z)] calcd for (C22H24N4O4 + H)+ = 409, found 409. 
Crude yield: 60%. Purity: 96% (LC). 
(±)-(3R,4S)-4-(4-Methoxyphenyl)-1-methyl-3-{[3-(3-pyridyl)ureido]methyl}pyrrolidine-3-carboxylic 
 acid (14{2,8}): (From 6{2}) MS [APCI (m/z)] calcd for (C20H24N4O4 + H)+ = 385, found 385. Crude 
yield: 45%. Purity: 76% (LC). 
(±)-(3R,4S)-4-(3,5-Dimethoxyphenyl)-1-methyl-3-[(3-phenylureido)methyl]pyrrolidine-3-carboxylic 
acid (14{3,4}): (From 6{3}) MS [APCI (m/z)] calcd for (C22H27N3O5 + H)+ = 414, found 414. Crude 
yield: 76%. Purity: 97% (LC). 
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(±)-(3R,4S)-4-(3,5-Dimethoxyphenyl)-1-methyl-3-({3-[4-(trifluoromethyl)phenyl]ureido}methyl)pyrro-
lidine-3-carboxylic acid (14{3,5}): (From 6{3}) MS [APCI (m/z)] calcd for (C23H26F3N3O5 + H)+ = 
482, found 482. Crude yield: 63%. Purity: 99% (LC). 
(±)-(3R,4S)-4-(3,5-Dimethoxyphenyl)-3-{[3-(4-ethoxyphenyl)ureido]methyl}-1-methylpyrrolidine-3- 
carboxylic acid (14{3,6}): (From 6{3}) 1H-NMR [300 MHz, δ (ppm), CD3SOCD3]: 8.83 (bs, 1 1H, 
NHAr), 7.30–7.21 (m, 2 1H, 2′′-CH + 6′′-CH), 6.79–6.70 (m, 2 1H, 3′′-CH + 5′′-CH), 6.47 (d, J = 2.1 
Hz, 2 1H, 2′-CH + 6′-CH), 6.41 (t, J = 2.1 Hz, 1 1H, 4′-CH), 6.12 (bs, 1 1H, CH2NH), 3.92 (q, J = 6.9 
Hz, 2 1H, CH2CH3), 3.72 (s, 6 1H, 2 × OCH3), 3.74–3.68 (m, 1 1H, 4-CH), 3.45 (d, J = 10.2 Hz, 1 1H, 
2-CHH), 3.39 (dd; J = 9.6, 7.5 Hz; 1 1H, 5-CHH), 3.24–3.18 (m, 1 1H, 5-CHH), 3.17 (dd; J = 12.9, 8.1 
Hz; 1 1H, CHHNH), 2.86 (d, J = 10.2 Hz, 1 1H, 2-CHH), 2.64 (s, 3 1H, NCH3), 2.59 (dd; J = 12.9, 2.1 
Hz; 1 1H, CHHNH), 1.28 (t, J = 6.9 Hz, 1 1H, CH2CH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 176.7 
(CO2), 160.2 (3′-C + 5′-C), 155.6 (NCON), 152.9 (4′′-C), 139.9 (1′-C), 133.9 (1′′-C), 119.0 (2′′-C + 6′′-
C), 114.4 (3′′-C + 5′′-C), 107.1 (2′-C + 6′-C), 98.3 (4′-C), 63.0 (CH2CH3), 62.2 (2-C), 59.1 (5-C), 55.8 
(3-C), 55.1 (2 × OCH3), 49.8 (4-C), 42.6 (NCH3), 40.8 (CH2NH), 14.7 (CH2CH3). FTIR [
_ν  (cm–1), 
neat]: 3354, 3250, 2947, 2836, 1671, 1594, 1542, 1204, 1153, 824. MS [APCI (m/z)] calcd for 
(C24H31N3O6 + H)+ = 458, found 458. Crude yield: 52%. Purity: 99% (LC). 
(±)-(3R,4S)-3-{[3-(3-Cyanophenyl)ureido]methyl}-4-(3,5-dimethoxyphenyl)-1-methylpyrrolidine-3- 
carboxylic acid (14{3,7}): (From 6{3}) 1H-NMR [300 MHz, δ (ppm), CD3SOCD3]: 9.88 (bs, 1 1H, 
NHAr), 7.99 (s, 1 1H, 2′-CH), 7.63 (d, J = 8.4 Hz, 1 1H, 6′-CH), 7.38 (app t, J = 7.8 Hz, 1 1H, 5′-CH), 
7.28 (d, J = 7.5 Hz, 1 1H, 4′-CH), 6.66 (bs, 1 1H, CH2NH), 6.47 (d, J = 2.1 Hz, 2 1H, 2′′-CH + 6′′-CH), 
6.40 (t, J = 2.1 Hz, 1 1H, 4′′-CH), 3.77 (app t, J = 8.7 Hz, 1 1H, 4-CH), 3.71 (s, 6 1H, 2 × OCH3), 3.59 
(d, J = 10.5 Hz, 1 1H, 2-CHH), 3.54 (dd; J = 9.9, 7.5 Hz; 1 1H, 5-CHH), 3.37 (app t, J = 9.0 Hz, 1 1H, 
5-CHH), 3.23 (dd; J = 12.8, 8.4 Hz; 1 1H, CHHNH), 2.97 (d, J = 10.5 Hz, 1 1H, 2-CHH), 2.75 (s, 3 1H, 
NCH3), 2.63 (dd; J = 12.8, 1.8 Hz; 1 1H, CHHNH). 13C-NMR [75 MHz, δ (ppm), CD3SOCD3]: 176.7 
(CO2), 160.2 (3′′-C + 5′′-C), 155.4 (NCON), 141.8 (1′-C), 139.3 (1′′-C), 129.9 (5′-C), 124.0 (4′-C), 
122.0 (6′-C), 119.8 (2′-C), 119.1 (CN), 111.3 (3′-C), 107.0 (2′′-C + 6′′-C), 98.4 (4′′-C), 62.3 (2-C), 58.6 
(5-C), 55.9 (3-C), 55.1 (2 × OCH3), 49.8 (4-C), 42.4 (NCH3), 40.7 (CH2NH). FTIR [
_ν  (cm–1), neat]: 
3377, 3184, 2942, 2838, 2790, 2234, 1679, 1594, 1543, 1203, 1150, 830. MS [APCI (m/z)] calcd for 
(C23H26N4O5 + H)+ = 439, found 439. Crude yield: 58%. Purity: >99% (LC). 
(±)-(3R,4S)-4-(3,5-Dimethoxyphenyl)-1-methyl-3-{[3-(3-pyridyl)ureido]methyl}pyrrolidine-3-car- 
boxylic acid (14{3,8}): (From 6{3}) MS [APCI (m/z)] calcd for (C21H26N4O5 + H)+ = 415, found 415. 
Crude yield: 48%. Purity: 43% (LC). 
(±)-(3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-methyl-3-[(3-phenylureido)methyl]pyrrolidine-3-carboxylic  
acid (14{4,4}): (From 6{4}) 1H-NMR [300 MHz, δ (ppm), CD3SOCD3]: 9.01 (bs, 1 1H, NHPh), 7.42–
7.34 (m, 2 1H, 2′′-CH + 6′′-CH), 7.22–7.12 (m, 2 1H, 3′′-CH + 5′′-CH), 6.96 (d, J = 1.2 Hz, 1 1H, 4′-
CH), 6.86 (d, J = 8.1 Hz, 1 1H, 7′-CH), 6.87–6.80 (m, 1 1H, 4′′-CH), 6.76 (dd; J = 8.1, 1.2 Hz; 1 1H, 6′-
CH), 6.26 (bd, J = 6.0 Hz, 1 1H, CH2NH), 6.01–5.97 (m, 2 1H, 2′-CH2), 3.72 (app t, J = 8.2 Hz, 1 1H, 
4-CH), 3.46 (d, J = 10.5 Hz, 1 1H, 2-CHH), 3.42 (dd; J = 9.9, 7.5 Hz; 1 1H, 5-CHH), 3.25–3.17 (m, 1 
1H, 5-CHH), 3.16 (dd; J = 12.9, 8.4 Hz; 1 1H, CHHNH), 2.88 (d, J = 10.5 Hz, 1 1H, 2-CHH), 2.65 (s, 3 
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1H, NCH3), 2.58 (dd; J = 12.9, 2.4 Hz; 1 1H, CHHNH). 13C-NMR [75 MHz, δ (ppm), CD3SOCD3]: 
176.7 (CO2), 155.4 (NCON), 147.1 (3′a-C), 146.1 (7′a-C), 140.8 (1′′-C), 131.3 (5′-C), 128.5 (3′′-C + 
5′′-C), 121.9 (6′-C), 120.7 (4′′-C), 117.4 (2′′-C + 6′′-C), 108.9 (7′-C), 107.9 (4′-C), 100.9 (2′-C), 62.2 
(2-C), 59.4 (5-C), 55.9 (3-C), 49.5 (4-C), 42.8 (NCH3), 40.5 (CH2NH). FTIR [
_ν  (cm–1), neat]: 3359, 
3254, 2954, 2898, 2780, 1671, 1597, 1549, 1495, 1228, 1035, 931, 756, 694. MS [APCI (m/z)] calcd 
for (C21H23N3O5 + H)+ = 398, found 398. Crude yield: 74%. Purity: >99% (LC). 
(±)-(3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-methyl-3-({3-[4-(trifluoromethyl)phenyl]ureido}methyl)pyrrol-
idine-3-carboxylic acid (14{4,5}): (From 6{4}) FTIR [
_ν  (cm–1), neat]: 3358, 3254, 2958, 2904, 1675, 
1601, 1546, 1504, 1489, 1321, 1231, 1035, 931. MS [APCI (m/z)] calcd for (C22H22F3N3O5 + H)+ = 
466, found 466. Crude yield: 68%. Purity: >99% (LC). 
(±)-(3R,4S)-4-(1,3-Benzodioxol-5-yl)-3-{[3-(4-ethoxyphenyl)ureido]methyl}-1-methylpyrrolidine-3- 
carboxylic acid (14{4,6}): (From 6{4}) MS [APCI (m/z)] calcd for (C23H27N3O6 + H)+ = 442, found 
442. Crude yield: 61%. Purity: 77% (LC). 
(±)-(3R,4S)-4-(1,3-Benzodioxol-5-yl)-3-{[3-(3-cyanophenyl)ureido]methyl}-1-methylpyrrolidine-3- 
carboxylic acid (14{4,7}): (From 6{4}) MS [APCI (m/z)] calcd for (C22H22N4O5 + H)+ = 423, found 
423. Crude yield: 62%. Purity: 99% (LC). 
(±)-(3R,4S)-4-(1,3-Benzodioxol-5-yl)-1-methyl-3-{[3-(3-pyridyl)ureido]methyl}pyrrolidine-3-car- 
boxylic acid (14{4,8}): (From 6{4}) MS [APCI (m/z)] calcd for (C20H22N4O5 + H)+ = 399, found 399. 
Crude yield: 54%. Purity: 71% (LC). 
(±)-(3R,4S)-1-Methyl-4-(1-methyl-1H-pyrrol-2-yl)-3-[(3-phenylureido)methyl]pyrrolidine-3- 
carboxylic acid (14{5,4}): (From 6{5}) MS [APCI (m/z)] calcd for (C19H24N4O3 + H)+ = 357, found 
357. Crude yield: 58%. Purity: 14% (LC). 
(±)-(3R,4S)-1-Methyl-4-(1-methyl-1H-pyrrol-2-yl)-3-({3-[4-(trifluoromethyl)phenyl]ureido}methyl)- 
pyrrolidine-3-carboxylic acid (14{5,5}): (From 6{5}) MS [APCI (m/z)] calcd for (C20H23F3N4O3 + 
H)+ = 425, found 425. Crude yield: 65%. Purity: 79% (LC). 
(±)-(3R,4S)-3-{[3-(4-Ethoxyphenyl)ureido]methyl}-1-methyl-4-(1-methyl-1H-pyrrol-2-yl)pyrrolidine- 
3-carboxylic acid (14{5,6}): (From 6{5}) MS [APCI (m/z)] calcd for (C21H28N4O4 + H)+ = 401, found 
401. Crude yield: 62%. Purity: 16% (LC). 
(±)-(3R,4S)-3-{[3-(3-Cyanophenyl)ureido]methyl}-1-methyl-4-(1-methyl-1H-pyrrol-2-yl)pyrrolidine-3-
carboxylic acid (14{5,7}): (From 6{5}) MS [APCI (m/z)] calcd for (C20H23N5O3 + H)+ = 382, found 
382. Crude yield: 61%. Purity: 99% (LC). 
(±)-(3R,4S)-1-Methyl-4-(1-methyl-1H-indol-3-yl)-3-[(3-phenylureido)methyl]pyrrolidine-3-carboxylic 
acid (14{6,4}): (From 6{6}) MS [APCI (m/z)] calcd for (C23H26N4O3 + H)+ = 407, found 407. Crude 
yield: 79%. Purity: 97% (LC). 
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(±)-(3R,4S)-1-Methyl-4-(1-methyl-1H-indol-3-yl)-3-({3-[4-(trifluoromethyl)phenyl]ureido}methyl)-
pyrrolidine-3-carboxylic acid (14{6,5}): (From 6{6}) MS [APCI (m/z)] calcd for (C24H25F3N4O3 + 
H)+ = 475, found 475. Crude yield: 76%. Purity: >99% (LC). 
(±)-(3R,4S)-3-{[3-(4-Ethoxyphenyl)ureido]methyl}-1-methyl-4-(1-methyl-1H-indol-3-yl)pyrrolidine-3-
carboxylic acid (14{6,6}): (From 6{6}) 1H-NMR [400 MHz, δ (ppm), CD3SOCD3]: 8.92 (bs, 1 1H, 
NHAr), 7.62 (d, J = 7.8 Hz, 1 1H, 4′′-CH), 7.38 (d, J = 8.4 Hz, 1 1H, 7′′-CH), 7.34 (s, 1 1H, 2′′-CH), 
7.29–7.21 (m, 2 1H, 2′-CH + 6′-CH), 7.12 (app t, J = 7.5 Hz, 1 1H, 6′′-CH), 6.96 (app t, J = 7.5 Hz, 1 
1H, 5′′-CH), 6.77–6.69 (m, 2 1H, 3′-CH + 5′-CH), 6.18 (bd, J = 6.9 Hz, 1 1H, CH2NH), 4.11 (dd;  
J = 9.6, 7.5 Hz; 1 1H, 4-CH), 3.91 (q, J = 6.9 Hz, 2 1H, CH2CH3), 3.77 (s, 3 1H, 1′′-NCH3), 3.54 (d,  
J = 10.2 Hz, 1 1H, 2-CHH), 3.53–3.49 (m, 1 1H, 5-CHH), 3.21 (dd; J = 13.2, 8.4 Hz; 1 1H, CHHNH), 
3.22–3.16 (m, 1 1H, 5-CHH), 2.86 (d, J = 10.2 Hz, 1 1H, 2-CHH), 2.68 (s, 3 1H, 1-NCH3), 2.66 (dd;  
J = 13.2, 2.1 Hz; 1 1H, CHHNH), 1.27 (t, J = 6.9 Hz, 3 1H, CH2CH3). FTIR [
_ν  (cm–1), neat]: 3330, 
2938, 2880, 1664, 1595, 1540, 827, 733. MS [APCI (m/z)] calcd for (C25H30N4O4 + H)+ = 451, found 
451. Crude yield: 70%. Purity: 94% (LC). 
(±)-(3R,4S)-3-{[3-(3-Cyanophenyl)ureido]methyl}-1-methyl-4-(1-methyl-1H-indol-3-yl)pyrrolidine-3-
carboxylic acid (14{6,7}): (From 6{6}) 1H-NMR [400 MHz, δ (ppm), CD3SOCD3]: 10.07 (bs, 1 1H, 
NHAr), 8.02 (s, 1 1H, 2′-CH), 7.67 (d, J = 8.1 Hz, 1 1H, 6′-CH), 7.61 (d, J = 7.8 Hz, 1 1H, 4′′-CH), 
7.39–7.36 (m, 1 1H, 7′′-CH), 7.37 (app t, J = 7.8 Hz, 1 1H, 5′-CH), 7.36 (s, 1 1H, 2′′-CH), 7.27 (d, J = 
7.5 Hz, 1 1H, 4′-CH), 7.10 (app t, J = 7.5 Hz, 1 1H, 6′′-CH), 6.88 (app t, J = 7.5 Hz, 1 1H, 5′′-CH), 6.74 
(bs, 1 1H, CH2NH), 4.17 (dd; J = 9.9, 7.8 Hz; 1 1H, 4-CH), 3.77 (s, 3 1H, 1′′-NCH3), 3.73–3.63 (m, 2 
1H, 2-CHH + 5-CHH), 3.36 (app t, J = 9.9 Hz, 1 1H, 5-CHH), 3.29 (dd; J = 13.4, 9.0 Hz; 1 1H, 
CHHNH), 2.99 (d, J = 9.9 Hz, 1 1H, 2-CHH), 2.80 (s, 3 1H, 1-NCH3), 2.68 (dd; J = 13.4, 2.1 Hz; 1 1H, 
CHHNH). 13C-NMR [75 MHz, δ (ppm), CD3SOCD3]: 177.3 (CO2), 155.5 (NCON), 142.0 (1′-C), 
136.6 (7′′a-C), 129.8 (5′-C), 127.7 (3′′a-C), 127.6 (2′′-C), 123.9 (4′-C), 122.0 (6′-C), 121.3 (6′′-C), 
119.8 (2′-C), 119.4 (5′′-C), 119.1 (CN), 118.6 (4′′-C), 111.3 (3′-C), 109.6 (3′′-C), 109.3 (7′′-C), 62.6 
(2-C), 59.1 (5-C), 55.4 (3-C), 42.4 (1-NCH3), 41.9 (4-C), 41.0 (CH2NH), 32.5 (1′′-NCH3). FTIR [
_ν  
(cm–1), neat]: 3361, 2940, 2226, 1685, 1583, 1564, 742. MS [APCI (m/z)] calcd for (C24H25N5O3 + H)+ 
= 432, found 432. Crude yield: 67%. Purity: 99% (LC). 
(±)-(3R,4S)-1-Methyl-4-(1-methyl-1H-indol-3-yl)-3-{[3-(3-pyridyl)ureido]methyl}pyrrolidine-3-car-
boxylic acid (14{6,8}): (From 6{6}) MS [APCI (m/z)] calcd for (C22H25N5O3 + H)+ = 408, found 408. 
Crude yield: 71%. Purity: 36% (LC). 
(±)-Methyl (3R,4S)-1-methyl-4-phenyl-3-[(3-phenylureido)methyl]pyrrolidine-3-carboxylate (15{1,4}): 
Phenyl isocyanate (2.563 g, 21.52 mmol) was added to a solution of α-aminomethyl ester 6{1} (4.858 
g, 19.56 mmol) in dry CH2Cl2 (40 mL). The resulting reaction mixture was stirred at room temperature 
for 2.5 h and the solvent was then evaporated to afford 15{1,4} (6.895 g, 96%) as a white foam, after 
column chromatography (CH2Cl2/MeOH, 14:1). 1H-NMR [300 MHz, δ (ppm), CDCl3]: 7.47 (bs, 1 1H, 
NHPh), 7.28–7.15 (m, 9 1H, Ph′ + 2′′-CH + 3′′-CH + 5′′-CH + 6′′-CH), 7.03–6.96 (m, 1 1H, 4′′-CH), 
5.35 (bdd; J = 7.8, 3.6 Hz; 1 1H, CH2NH), 3.91 (app t, J = 8.2 Hz, 1 1H, 4-CH), 3.70 (s, 3 1H, OCH3), 
3.44 (dd; J = 14.1, 8.4 Hz; 1 1H, CHHNH), 3.20 (d, J = 9.6 Hz, 1 1H, 2-CHH), 3.05 (app t, J = 8.6 Hz, 
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1 1H, 5-CHH), 2.96 (app t, J = 9.0 Hz, 1 1H, 5-CHH), 2.80 (dd; J = 14.1, 3.9 Hz; 1 1H, CHHNH), 2.72 
(d, J = 9.6 Hz, 1 1H, 2-CHH), 2.39 (s, 3 1H, NCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 176.0 
(CO2), 156.1 (NCON), 138.8 (1′′-C), 137.3 (1′-C), 129.0 (2′-C + 6′-C)*, 128.5 (3′-C + 5′-C)*, 128.4 
(3′′-C + 5′′-C)*, 127.2 (4′-C), 123.2 (4′′-C), 120.5 (2′′-C + 6′′-C), 63.3 (2-C), 60.4 (5-C), 57.0 (3-C), 
52.8 (OCH3), 50.8 (4-C), 44.0 (CH2NH), 42.3 (NCH3). FTIR [
_ν  (cm–1), neat]: 3323, 2952, 2836, 2790, 
1725, 1656, 1597, 1554, 751, 701. HRMS [ESI (m/z)] calcd for (C21H25N3O3 + H)+ = 368.19687, 
found 368.19803 (|Δ| = 1.7 ppm). RF: 0.40 (CH2Cl2/MeOH, 8:1). Mp: 160.6 °C. 
(±)-(4R,5S)-2-Methyl-4,7-diphenyl-2,7,9-triazaspiro[4.5]decane-6,8-dione (5{1,4}): A 1 M solution of 
KOBut in THF (120 μL, 120 μmol) was added to a solution of α-ureido ester 15{1,4} (44 mg, 120 
μmol) in THF (4 mL). The resulting reaction mixture was stirred for 55 min at 31 °C. Brine (1 mL) 
was then added. The layers were separated and the aqueous phase was extracted with CH2Cl2 (2 × 1.5 
mL). The combined organic layers were dried over Na2SO4 and concentrated in vacuo. The residue 
afforded 5{1,4} (23 mg, 57%) as a white solid, after column chromatography (CH2Cl2/MeOH, 19:1). 
1H-NMR [300 MHz, δ (ppm), CD3SOCD3]: 7.79 (bd, J = 3.0 Hz, 1 1H, NH), 7.43–7.20 (m, 8 1H, Ph′ + 
3′′-CH + 4′′-CH + 5′′-CH), 7.16–7.11 (m, 2 1H, 2′′-CH + 6′′-CH), 4.05 (app t, J = 6.9 Hz, 1 1H, 4-CH), 
2.98 (dd; J = 9.0, 6.6 Hz; 1 1H, 3-CHH), 2.95–2.84 (m, 4 1H, 1-CH2 + 3-CHH + 10-CHH), 2.67 (dd;  
J = 12.6, 1.5 Hz; 1 1H, 10-CHH), 2.36 (s, 3 1H, NCH3). 13C-NMR [75 MHz, δ (ppm), CDCl3]: 173.3 
(6-C), 153.9 (8-C), 139.0 (1′-C), 135.4 (1′′-C), 129.1 (3′′-C + 5′′-C), 128.63 (3′-C + 5′-C)*, 128.58 (2′′-
C + 6′′-C)*, 128.5 (2′-C + 6′-C)*, 128.4 (4′′-C), 127.2 (4′-C), 64.0 (1-C), 62.0 (3-C), 52.5 (5-C), 48.3 
(4-C), 43.7 (10-C), 42.1 (NCH3). FTIR [
_ν  (cm–1), neat]: 3254, 2945, 2835, 2792, 1725, 1684, 767, 
753, 707, 693. Elem. anal. calcd for C20H21N3O2: C 71.62%, H 6.31%, N 12.53%; found C 71.70%, H 
6.17%, N 12.48%. RF: 0.44 (CH2Cl2/MeOH, 8:1). Mp: 231.5 °C (from MeOH, colorless crystals). 
Purity: >99.5% (GC). 
5. Conclusions 
In summary, we have developed a general high-yielding method for the synthesis of trans-4-aryl-
substituted 3-(aminomethyl)pyrrolidine-3-carboxylates. We have shown that these aryl groups can be 
phenyl or electron-rich aryls (4-methoxyphenyl, 3,5-dimethoxyphenyl, and 1,3-benzodioxol-5-yl) and 
electron-rich heteroaryls (1-methylpyrrol-2-yl and 1-methylindol-3-yl). As a result, we anticipate that 
this methodology can be successfully applied for a wide range of aromatic groups, although with 
electron-poor heteroaryls (2-, 3-, and 4-pyridyl) mixtures of cis–trans isomers are formed after the 
cycloaddition step. 
We have also developed a method for the synthesis of a small library of 7-alkyldihydrouracils spiro-
fused to pyrrolidines to the 3-position. The corresponding 7-aryl derivatives hydrolyzed under the 
conditions utilized for the cyclization and yielded α-ureidomethyl acids. The optimization of this 
cyclization should be further developed. 
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